Home content

LOINC Prerelease Terms

979 New LOINC codes

Last updated 2019-11-26

DISCLAIMER

These codes are currently under development by the LOINC team, and are subject to change prior to inclusion in a public release. It is possible that they may not be published in the next, or any, public release. They are provided here for informational purposes only.

TIP Click on headings to sort table by that column. Hold down Shift and click additional headings to add to sorting.

TIP In your web browser, use ControlF (or ⌘F on Mac) to find text on this page.

scroll/swipe to view more columns

Created On LOINC Long Common Name Special Usage Component Prop Time System Scale Method Shortname
2019-11-18 94136-9 Controlled substance agreement Controlled substance agreement Find Pt {Setting} Doc {Role} Cntrl Substance Agreement
2019-11-18 94137-7 HEDIS 2020 Value Sets HEDIS 2020 Value Sets - Pt ^Patient - HEDIS 2020 Value Sets
2019-11-18 94138-5 HEDIS 2020 Value Set - BMI HEDIS 2020 Value Set - BMI - Pt ^Patient - HEDIS 2020 BMI
2019-11-18 94139-3 HEDIS 2020 Value Set - BMI percentile HEDIS 2020 Value Set - BMI percentile - Pt ^Patient - HEDIS 2020 BMI prctl
2019-11-18 94140-1 HEDIS 2020 Value Set - CT Colonography HEDIS 2020 Value Set - CT Colonography - Pt ^Patient - HEDIS 2020 CT Colongrphy
2019-11-18 94141-9 HEDIS 2020 Value Set - Mammography HEDIS 2020 Value Set - Mammography - Pt ^Patient - HEDIS 2020 Mammography
2019-11-18 94142-7 HEDIS 2020 Value Set - Urine Protein Tests HEDIS 2020 Value Set - Urine Protein Tests - Pt ^Patient - HEDIS 2020 Urine Prot Tests
2019-11-10 94130-2 Body disposition facility name [Identifier] Body disposition facility name ID Pt Facility Nom Body disposition facility name
2019-11-10 94131-0 Body disposition facility address Body disposition facility address Addr Pt Facility Nom Body disposition facility address
2019-11-10 94132-8 Funeral facility name [Identifier] Funeral facility name ID Pt Facility Nom Funeral facility name
2019-11-10 94133-6 Funeral facility address Funeral facility address Addr Pt Facility Nom Funeral facility address
2019-11-10 94134-4 Personnel Funeral service licensee or other agent assuming custody of the body of the deceased Funeral service licensee or other agent assuming custody of the body of the deceased Pn Pt Personnel Nom Personnel Funeral service licensee
2019-11-10 94135-1 Funeral service licensee identifier Facility Funeral service licensee identifier ID Pt Facility Nom Funeral service licensee ID Facility
2019-11-09 94122-9 Oxygen consumption (VO2)/Body weight [Volume Rate Content] --peak during exercise Oxygen consumption/Body weight^peak during exercise VRatCnt Pt ^Patient Qn VO2/BW max dur exercise
2019-11-09 94123-7 Pulmonary artery End diastolic blood pressure by Cardiac catheterization Intravascular end diastolic Pres Pt Pulmonary artery Qn Cardiac catheterization dPAP by Cardiac cath
2019-11-09 94124-5 Ventilatory threshold [Volume Rate Content] Ventilatory threshold VRatCnt Pt ^Patient Qn Ventilatory threshold
2019-11-09 94125-2 Residual volume/Predicted by Plethysmograph body box Volume.residual/Predicted VFr Pt Respiratory system Qn Plethysmograph.body box Residual vol/Predicted Plethysmograph
2019-11-09 94126-0 Ventilatory equivalent for carbon dioxide --W exercise Ventilatory equivalent for carbon dioxide^W exercise VRto Pt ^Patient Qn VEqCO2 W exercise
2019-11-09 94127-8 Clarity of Body fluid Clarity Type Pt Body fld Nom Clarity Fld
2019-11-09 94128-6 Vasopressin challenge post water deprivation panel - Urine and Serum or Plasma Vasopressin challenge post water deprivation panel - Pt Urine+Ser/Plas - Vasopressin chal p H2O depr Pnl U+SerPl
2019-11-09 94129-4 Water deprivation challenge panel - Urine and Serum or Plasma Water deprivation challenge panel - Pt Urine+Ser/Plas - Water deprivation Pnl Ur+SerPl
2019-11-08 94054-4 Bacterial katG gene drug resistance mutation [Identifier] by Molecular method Bacterial katG gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial katG drug res mut Islt/Spm
2019-11-08 94055-1 Bacterial inhA gene drug resistance mutation [Identifier] by Molecular method Bacterial inhA gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial inhA drug res mut Islt/Spm
2019-11-08 94053-6 Mycobacterium tuberculosis complex resistance panel by Molecular genetics method Mycobacterium tuberculosis complex resistance panel - Pt Isolate/Specimen - Molgen MTB cmplx resist Pnl Islt/Spm
2019-11-08 94056-9 Bacterial fabG1 gene drug resistance mutation [Identifier] by Molecular method Bacterial fabG1 gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial fabG1 drug res mut Islt/Spm
2019-11-08 94057-7 Bacterial ahpC gene drug resistance mutation [Identifier] by Molecular method Bacterial ahpC gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial ahpC drug res mut Islt/Spm
2019-11-08 94058-5 Bacterial embB gene drug resistance mutation [Identifier] by Molecular method Bacterial embB gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial embB drug res mut Islt/Spm
2019-11-08 94059-3 Bacterial pncA gene drug resistance mutation [Identifier] by Molecular method Bacterial pncA gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial pncA drug res mut Islt/Spm
2019-11-08 94060-1 Bacterial gyrA gene drug resistance mutation [Identifier] by Molecular method Bacterial gyrA gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial gyrA drug res mut Islt/Spm
2019-11-08 94061-9 Bacterial gidB gene drug resistance mutation [Identifier] by Molecular method Bacterial gidB gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial gidB drug res mut Islt/Spm
2019-11-08 94064-3 Bacterial eis gene drug resistance mutation [Identifier] by Molecular method Bacterial eis gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial eis drug res mut Islt/Spm
2019-11-08 94062-7 Bacterial rrs gene drug resistance mutation [Identifier] by Molecular method Bacterial rrs gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial rrs drug res mut Islt/Spm
2019-11-08 94063-5 Bacterial rpsL gene drug resistance mutation [Identifier] by Molecular method Bacterial rpsL gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial rpsL drug res mut Islt/Spm
2019-11-08 94065-0 Bacterial rpoB gene drug resistance mutation [Identifier] by Molecular method Bacterial rpoB gene drug resistance mutation Prid Pt Isolate/Specimen Nom Molgen Bacterial rpoB drug res mut Islt/Spm
2019-11-08 94066-8 Person-Centered Primary Care Measure [PCPCM] Person-Centered Primary Care Measure - Pt ^Patient - PCPCM
2019-11-08 94067-6 Color Me Healthy - children's symptom assessment app Color Me Healthy - children's symptom assessment app panel - Pt ^Patient - Color Me Healthy panel
2019-11-08 94068-4 Symptom distress level Symptom distress level Find Pt ^Patient Ord Symptom distress level
2019-11-08 94069-2 Emesis occurred Emesis occurred Find Pt ^Patient Ord Emesis occurred
2019-11-08 94070-0 Emesis count 24 hour Emesis count NRat 24H ^Patient Qn Emesis count 24h nRate
2019-11-08 94072-6 Attended school today Attended school today Find Pt ^Patient Ord Attended school today
2019-11-08 94073-4 Best thing about your day Best thing about your day Find Pt ^Patient Nom Best thing about your day
2019-11-08 94074-2 Most bothersome concern Most bothersome concern Find Pt ^Patient Nom Most bothersome concern
2019-11-08 94075-9 Cause of sick feeling Cause of sick feeling Find Pt ^Patient Nom Cause of sick feeling
2019-11-08 94076-7 Mutations/Megabase [# Ratio] in Tumor Mutations/Megabase NRto Pt Tumor Qn Muts/Mb Tumor
2019-11-08 94077-5 Tumor mutation burden [Interpretation] Tumor mutation burden Imp Pt Tumor Ord TMB Tumor-Imp
2019-11-08 94078-3 PDX1 gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal PDX1 gene full mutation analysis Prid Pt Bld/Tiss Nom Sequencing PDX1 Full Mut Anl Bld/T Seq
2019-11-08 94080-9 RRM2B gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal RRM2B gene full mutation analysis Prid Pt Bld/Tiss Nom Sequencing RRM2B Full Mut Anl Bld/T Seq
2019-11-08 94079-1 TYMP gene mutations found [Identifier] in Blood or Tissue by Sequencing Nominal TYMP gene full mutation analysis Prid Pt Bld/Tiss Nom Sequencing TYMP Full Mut Anl Bld/T Seq
2019-11-08 94081-7 Validation error details Document Validation error details Find Pt Document Doc Validation error details Doc
2019-11-08 94082-5 Validation error summary Document Validation error summary Find Pt Document Doc Validation error summary Doc
2019-11-08 94083-3 Wound volume Wound volume Vol Pt Wound Qn Wound vol
2019-11-08 94084-1 Nonverbal pain indicators Nonverbal pain indicators Find Pt ^Patient Nom Nonverb pain ind
2019-11-08 94085-8 Pain category Pain category Type Pt ^Patient Nom Pain cat
2019-11-08 94086-6 Wound shape Wound shape Shape Pt Wound Nom Wnd shape
2019-11-08 94087-4 Chromosome analysis in Blood or Tissue by Microarray Chromosome analysis Find Pt Bld/Tiss Doc Microarray Chrom analy Bld/T Microarray
2019-11-08 94088-2 MR Thoracic and lumbar spine WO and W contrast Multisection^WO & W contrast Find Pt Chest>Spine.thoracic & Abdomen>Spine.lumbar Doc MR MR T+L-Spine WO+W contr
2019-11-08 94089-0 MR Chest WO and W contrast IV and MRA Chest W contrast IV Multisection^WO & W contrast IV && Multisection^W contrast IV Find Pt Chest Doc MR && MR.angio MR Chest WO+W contr IV+MRA W contr IV
2019-11-08 94091-6 RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty Find Pt XXX>Vessels Doc RF.angio RFA dial fist W c IA + PTA
2019-11-08 94090-8 RFA Views for dialysis fistula W contrast IA and Guidance for percutaneous transluminal angioplasty transcatheter placement of stent Views for dialysis fistula^W contrast IA & Guidance for percutaneous transluminal angioplasty + transcatheter placement of stent Find Pt XXX>Vessels Doc RF.angio RFA dial fist W c IA + PTA + stent place
2019-11-08 94092-4 RFA Views for dialysis fistula W contrast IA Views for dialysis fistula^W contrast IA Find Pt XXX>Vessels Doc RF.angio RFA Vs for dial fistula W contr IA
2019-11-08 94093-2 Itemized bill Document Itemized bill Find Pt ^Patient Doc Itemized bill
2019-11-08 94094-0 RFA Unspecified body region Limited Views for therapy or embolization or infusion W contrast via existing catheter Views limited for therapy or embolization or infusion^W contrast via existing catheter Find Pt XXX Doc RF.angio RFA Vs Ltd W contr via exist cath
2019-11-08 94095-7 RFA Extremity vessels Unilateral Views W contrast IV Views^W contrast IV Find Pt Extremity.unilateral>Extremity vessels Doc RF.angio RFA Ext ves-Ul Views W contr IV
2019-11-08 94096-5 Collagen type VII IgG Ab [Presence] in Serum or Plasma by Immunoassay Collagen type VII Ab.IgG PrThr Pt Ser/Plas Ord IA CollagenVII IgG SerPl Ql IA
2019-11-08 94097-3 Cytosolic 5'-nucleotidase 1A IgG Ab [Presence] in Serum or Plasma by Immunoassay Cytosolic 5'-nucleotidase 1A Ab.IgG PrThr Pt Ser/Plas Ord IA cN-1A IgG SerPl Ql IA
2019-11-08 94099-9 Hantavirus IgM Ab [Presence] in Serum or Plasma by Immunofluorescence Hantavirus Ab.IgM PrThr Pt Ser/Plas Ord IF Hantavirus IgM SerPl Ql IF
2019-11-08 94098-1 Dense fine speckled 70 protein IgG Ab [Presence] in Serum or Plasma by Immunoassay Dense fine speckled 70 protein Ab.IgG PrThr Pt Ser/Plas Ord IA DFS70 IgG SerPl Ql IA
2019-11-08 94100-5 Hantavirus seoul IgM Ab [Presence] in Serum or Plasma by Line blot Hantavirus seoul Ab.IgM PrThr Pt Ser/Plas Ord Line blot H seoul IgM SerPl Ql Line blot
2019-11-08 94101-3 Hantavirus seoul IgG Ab [Presence] in Serum or Plasma by Line blot Hantavirus seoul Ab.IgG PrThr Pt Ser/Plas Ord Line blot H seoul IgG SerPl Ql Line blot
2019-11-08 94102-1 Epstein Barr virus early diffuse IgA Ab [Units/volume] in Serum or Plasma by Immunoassay Epstein Barr virus early diffuse Ab.IgA ACnc Pt Ser/Plas Qn IA EBV EA-D IgA SerPl IA-aCnc
2019-11-08 94104-7 Zolpidem [Presence] in Urine by Screen method Zolpidem PrThr Pt Urine Ord Screen Zolpidem Ur Ql Scn
2019-11-08 94103-9 Zolpidem phenyl-4-carboxylate [Presence] in Urine by Screen method Zolpidem phenyl-4-carboxylate PrThr Pt Urine Ord Screen Zolpidem phenyl-4-carb Ur Ql Scn
2019-11-08 94108-8 1-Hydroxymidazolam [Presence] in Urine by Screen method 1-Hydroxymidazolam PrThr Pt Urine Ord Screen 1OH-midazolam Ur Ql Scn
2019-11-08 94107-0 Oxazepam glucuronide [Presence] in Urine by Screen method Oxazepam glucuronide PrThr Pt Urine Ord Screen Oxazepam glucuronide Ur Ql Scn
2019-11-08 94105-4 Alpha hydroxytriazolam [Presence] in Urine by Screen method Alpha hydroxytriazolam PrThr Pt Urine Ord Screen A-OH-triazolam Ur Ql Scn
2019-11-08 94106-2 Temazepam glucuronide [Presence] in Urine by Screen method Temazepam glucuronide PrThr Pt Urine Ord Screen Temazepam glucuronide Ur Ql Scn
2019-11-08 94111-2 7-Aminoflunitrazepam [Presence] in Urine by Screen method 7-Aminoflunitrazepam PrThr Pt Urine Ord Screen 7Aminoflunitrazepam Ur Ql Scn
2019-11-08 94109-6 LORazepam glucuronide [Presence] in Urine by Screen method LORazepam glucuronide PrThr Pt Urine Ord Screen LORazepam glucuronide Ur Ql Scn
2019-11-08 94110-4 2-Hydroxyethylflurazepam [Presence] in Urine by Screen method 2-Hydroxyethylflurazepam PrThr Pt Urine Ord Screen 2-OH-Ethylfluraz Ur Ql Scn
2019-11-08 94114-6 cloBAZam [Presence] in Urine by Screen method cloBAZam PrThr Pt Urine Ord Screen cloBAZam Ur Ql Scn
2019-11-08 94113-8 Norclobazam [Presence] in Urine by Screen method Norclobazam PrThr Pt Urine Ord Screen Norclobazam Ur Ql Scn
2019-11-08 94112-0 7-Aminoclonazepam [Presence] in Urine by Screen method 7-Aminoclonazepam PrThr Pt Urine Ord Screen 7AminoclonazePAM Ur Ql Scn
2019-11-08 94115-3 Alpha hydroxyalprazolam glucuronide [Presence] in Urine by Screen method Alpha hydroxyalprazolam glucuronide PrThr Pt Urine Ord Screen A-OH Alpraz gluc Ur Ql Scn
2019-11-08 94116-1 ALPRAZolam [Presence] in Urine by Screen method ALPRAZolam PrThr Pt Urine Ord Screen Alpraz Ur Ql Scn
2019-11-08 94117-9 Benzodiazepines panel [Presence] - Urine by Screen method Benzodiazepines panel PrThr Pt Urine Ord Screen Benzodiazepines Pnl Ur Scn
2019-11-08 94118-7 Medical records in response to authorization denial Medical records in response to authorization denial Find Pt ^Patient Doc Med records p auth denial
2019-11-08 94119-5 Expired minute volume/Carbon dioxide production during exercise Volume.expired per minute/Carbon dioxide production^W exercise VRto Pt ^Patient Qn VE/VCO2 slope dur exercise
2019-11-08 94121-1 Inferior vena cava Blood pressure by US Intravascular Pres Pt Vena cava.inferior Qn US IVC BP by US
2019-11-08 94120-3 Oxygen consumption (VO2)/Heart rate --peak during exercise Oxygen consumption/Heart rate^peak during exercise VRat Pt ^Patient Qn Peak oxygen pulse
2019-11-07 93871-2 Borrelia miyamotoi IgG+IgM Ab [Interpretation] in Serum or Plasma Borrelia miyamotoi Ab.IgG+IgM Imp Pt Ser/Plas Nom B miyamotoi IgG+IgM SerPl-Imp
2019-11-07 93872-0 Tamoxifen metabolites pattern [Interpretation] in Serum or Plasma Tamoxifen metabolites pattern Imp Pt Ser/Plas Nom Tamoxifen metab pattern SerPl-Imp
2019-11-07 93873-8 Borrelia miyamotoi IgG Ab [Units/volume] in Serum or Plasma by Immunoassay Borrelia miyamotoi Ab.IgG ACnc Pt Ser/Plas Qn IA B miyamotoi IgG SerPl IA-aCnc
2019-11-07 93874-6 Borrelia miyamotoi IgM Ab [Units/volume] in Serum or Plasma by Immunoassay Borrelia miyamotoi Ab.IgM ACnc Pt Ser/Plas Qn IA B miyamotoi IgM SerPl IA-aCnc
2019-11-07 93875-3 Phosphohistone H3 [Presence] in Tissue by Immune stain Phosphohistone H3 PrThr Pt Tiss Ord Immune stain PHH3 Tiss Ql ImStn
2019-11-07 93876-1 Ceramide risk score in Plasma by calculation Ceramide risk score Score Pt Plas Qn Calculated Ceramide risk score Plas Calc
2019-11-07 93877-9 N-Nervonoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma N-Nervonoylsphingosine/N-Lignoceroylsphingosine SRto Pt Plas Qn C24:1 ceramide/C24 ceramide Plas-sRto
2019-11-07 93878-7 N-Stearoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma N-Stearoylsphingosine/N-Lignoceroylsphingosine SRto Pt Plas Qn C18 ceramide/C24 ceramide Plas-sRto
2019-11-07 93879-5 N-Palmitoylsphingosine/N-Lignoceroylsphingosine [Molar ratio] in Plasma N-Palmitoylsphingosine/N-Lignoceroylsphingosine SRto Pt Plas Qn C16 ceramide/C24 ceramide Plas-sRto
2019-11-07 93880-3 N-Nervonoylsphingosine [Moles/volume] in Plasma N-Nervonoylsphingosine SCnc Pt Plas Qn C24:1 ceramide Plas-sCnc
2019-11-07 93881-1 N-Stearoylsphingosine [Moles/volume] in Plasma N-Stearoylsphingosine SCnc Pt Plas Qn C18 ceramide Plas-sCnc
2019-11-07 93882-9 N-Palmitoylsphingosine [Moles/volume] in Plasma N-Palmitoylsphingosine SCnc Pt Plas Qn C16 ceramide Plas-sCnc
2019-11-07 93883-7 Ceramide panel - Plasma Ceramide panel - Pt Plas Qn Ceramide Pnl Plas
2019-11-07 93884-5 Methane/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate Methane/Expired gas^2H post dose carbohydrate VFr Pt Exhl gas Qn Breath methane 2h p carb
2019-11-07 93888-6 Methane/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate Methane/Expired gas^30M post dose carbohydrate VFr Pt Exhl gas Qn Breath methane 30M p carb
2019-11-07 93885-2 Methane/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate Methane/Expired gas^1.5H post dose carbohydrate VFr Pt Exhl gas Qn Breath methane 1.5h p carb
2019-11-07 93886-0 Methane/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate Methane/Expired gas^1H post dose carbohydrate VFr Pt Exhl gas Qn Breath methane 1h p carb
2019-11-07 93887-8 Methane/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate Methane/Expired gas^45M post dose carbohydrate VFr Pt Exhl gas Qn Breath methane 45M p carb
2019-11-07 93891-0 Methane/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate Methane/Expired gas^post dose carbohydrate VFr Pt Exhl gas Qn Breath methane p carb
2019-11-07 93889-4 Methane/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate Methane/Expired gas^15M post dose carbohydrate VFr Pt Exhl gas Qn Breath methane 15M p carb
2019-11-07 93890-2 Methane/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate Methane/Expired gas^pre dose carbohydrate VFr Pt Exhl gas Qn Breath methane pre carb
2019-11-07 93892-8 Addiction medicine Progress note Progress note Find Pt {Setting} Doc Addiction medicine Addiction med Progress note
2019-11-07 93893-6 Orthopaedic surgery Team Conference note Conference note Find Pt {Setting} Doc Orthopaedic surgery.team Ortho surg Team Conf eval note
2019-11-07 93894-4 Hematology Team Conference note Conference note Find Pt {Setting} Doc Hematology.team Hematology Team Conf eval note
2019-11-07 93896-9 Gynecologic oncology Telephone encounter Note Note Find Pt Telephone encounter Doc Gynecologic oncology Gyn Onc Phone Note
2019-11-07 93897-7 Maternal and fetal medicine Progress note Progress note Find Pt {Setting} Doc Maternal and fetal medicine Maternal fetal med Progress note
2019-11-07 93895-1 Gynecologic oncology Team Conference note Conference note Find Pt {Setting} Doc Gynecologic oncology.team Gyn onc Team Conf eval note
2019-11-07 93898-5 Family medicine Telephone encounter Note Note Find Pt Telephone encounter Doc Family medicine Fam Med Phone Note
2019-11-07 93899-3 Psychiatry Letter Letter Find Pt {Setting} Doc Psychiatry Psychiatric Letter
2019-11-07 93900-9 Healthcare navigator Progress note Progress note Find Pt {Setting} Doc Healthcare navigator Navigator Progress note
2019-11-07 93901-7 Healthcare navigator Telephone encounter Note Note Find Pt Telephone encounter Doc Healthcare navigator Navigator Phone Note
2019-11-07 93902-5 Healthcare navigator Plan of care note Plan of care note Find Pt {Setting} Doc Healthcare navigator Navigator Plan of care note
2019-11-07 93903-3 Healthcare navigator Discharge summary Discharge summary note Find Pt {Setting} Doc Healthcare navigator Navigator Discharge sum
2019-11-07 93905-8 ABO group [Type] in Blood--during infancy ABO group^during infancy Type Pt Bld Nom ABO Group infant Bld
2019-11-07 93904-1 Transfusion reaction panel Transfusion reaction panel - Pt ^Patient - Transf React Pnl
2019-11-07 93906-6 ABO and Rh group [Type] in Blood--during infancy ABO & Rh group^during infancy Type Pt Bld Nom ABO + Rh infant Bld
2019-11-07 93907-4 Lu 20 Ag [Presence] on Red Blood Cells L little u 20 Ag PrThr Pt RBC Ord Lu 20 Ag RBC Ql
2019-11-07 93908-2 Au sup(b) Ag [Presence] on Red Blood Cells A little u super little b Ag PrThr Pt RBC Ord Au sup(b) Ag RBC Ql
2019-11-07 93911-6 little cE Ag [Presence] on Red Blood Cells little c E Ag PrThr Pt RBC Ord little cE Ag RBC Ql
2019-11-07 93912-4 CE Ag [Presence] on Red Blood Cells CE Ag PrThr Pt RBC Ord CE Ag RBC Ql
2019-11-07 93910-8 Fy3 Ag [Presence] on Red Blood Cells F little y3 Ag PrThr Pt RBC Ord Fy3 Ag RBC Ql
2019-11-07 93909-0 Jk3 Ag [Presence] on Red Blood Cells J little k3 Ag PrThr Pt RBC Ord Jk3 Ag RBC Ql
2019-11-07 93913-2 VS Ag [Presence] on Red Blood Cells VS Ag PrThr Pt RBC Ord VS Ag RBC Ql
2019-11-07 93914-0 Blood group antigens panel - Red Blood Cells Blood group antigens panel - Pt RBC - Bld Grp Ag Pnl RBC
2019-11-07 93915-7 Rh antigens and K Ag panel - Blood from Blood product unit Rh antigens & K Ag panel - Pt Bld^BPU - Rh Ags+K Ag Pnl Bld BPU
2019-11-07 93918-1 little e Ag [Presence] on Red Blood Cells --after transfusion reaction little e Ag^post transfusion reaction PrThr Pt RBC Ord little e Ag p transf rx RBC Ql
2019-11-07 93917-3 K Ag [Presence] on Red Blood Cells --after transfusion reaction K Ag^post transfusion reaction PrThr Pt RBC Ord K Ag p transf rx RBC Ql
2019-11-07 93916-5 ABO and Rh group panel - Blood from Blood product unit ABO & Rh group panel - Pt Bld^BPU - ABO + Rh Pnl Bld BPU
2019-11-07 93921-5 C Ag [Presence] on Red Blood Cells --after transfusion reaction C Ag^post transfusion reaction PrThr Pt RBC Ord C Ag p transf rx RBC Ql
2019-11-07 93919-9 little c Ag [Presence] on Red Blood Cells --after transfusion reaction little c Ag^post transfusion reaction PrThr Pt RBC Ord little c Ag p transf rx RBC Ql
2019-11-07 93920-7 E Ag [Presence] on Red Blood Cells --after transfusion reaction E Ag^post transfusion reaction PrThr Pt RBC Ord E Ag p transf rx RBC Ql
2019-11-07 93922-3 Rh antigens and K Ag post transfusion reaction panel - Blood Rh antigens & K Ag post transfusion reaction panel - Pt Bld - Rh Ags+K Ag Pnl p Transf Rx Bld
2019-11-07 93924-9 K Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant K Ag^post hematopoietic stem cell transplant PrThr Pt RBC Ord K Ag p HSCT RBC Ql
2019-11-07 93925-6 little e Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant little e Ag^post hematopoietic stem cell transplant PrThr Pt RBC Ord little e Ag p HSCT RBC Ql
2019-11-07 93923-1 ABO and Rh group post transfusion reaction panel - Blood ABO & Rh group post transfusion reaction panel - Pt Bld - ABO + Rh Pnl p transf rx Bld
2019-11-07 93926-4 little c Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant little c Ag^post hematopoietic stem cell transplant PrThr Pt RBC Ord little c Ag p HSCT RBC Ql
2019-11-07 93928-0 C Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant C Ag^post hematopoietic stem cell transplant PrThr Pt RBC Ord C Ag p HSCT RBC Ql
2019-11-07 93927-2 E Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant E Ag^post hematopoietic stem cell transplant PrThr Pt RBC Ord E Ag p HSCT RBC Ql
2019-11-07 93929-8 Rh antigens and K Ag post hematopoietic stem cell transplant panel - Blood Rh antigens & K Ag post hematopoietic stem cell transplant panel - Pt Bld - Rh Ags+K Ag Pnl p stem trnsplt Bld
2019-11-07 93930-6 D Ag [Presence] on Red Blood Cells --post hematopoietic stem cell transplant D Ag^post hematopoietic stem cell transplant PrThr Pt RBC Ord D Ag p HSCT RBC Ql
2019-11-07 93931-4 ABO group [Type] in Blood--post hematopoietic stem cell transplant ABO group^post hematopoietic stem cell transplant Type Pt Bld Nom ABO Group p HSCT Bld
2019-11-07 93932-2 ABO and Rh group [Type] in Blood--post hematopoietic stem cell transplant ABO & Rh group^post hematopoietic stem cell transplant Type Pt Bld Nom ABO + Rh p HSCT Bld
2019-11-07 93934-8 K Ag [Presence] on Red Blood Cells --during infancy K Ag^during infancy PrThr Pt RBC Ord K Ag infant RBC Ql
2019-11-07 93935-5 little e Ag [Presence] on Red Blood Cells --during infancy little e Ag^during infancy PrThr Pt RBC Ord little e Ag infant RBC Ql
2019-11-07 93936-3 little c Ag [Presence] on Red Blood Cells --during infancy little c Ag^during infancy PrThr Pt RBC Ord little c Ag infant RBC Ql
2019-11-07 93933-0 ABO and Rh group post hematopoietic stem cell transplant panel - Blood ABO & Rh group post hematopoietic stem cell transplant panel - Pt Bld - ABO+Rh Gp Pnl p stem trnsplt Bld
2019-11-07 93937-1 E Ag [Presence] on Red Blood Cells --during infancy E Ag^during infancy PrThr Pt RBC Ord E Ag infant RBC Ql
2019-11-07 93938-9 C Ag [Presence] on Red Blood Cells --during infancy C Ag^during infancy PrThr Pt RBC Ord C Ag infant RBC Ql
2019-11-07 93939-7 Rh antigens and K Ag during infancy panel - Blood Rh antigens & K Ag during infancy panel - Pt Bld - Rh Ags+K Ag Pnl infant Bld
2019-11-07 93942-1 K Ag [Presence] in Cord red blood cells K Ag PrThr Pt RBCCo Ord K Ag RBCCo Ql
2019-11-07 93943-9 little e Ag [Presence] in Cord red blood cells little e Ag PrThr Pt RBCCo Ord little e Ag RBCCo Ql
2019-11-07 93940-5 D Ag [Presence] on Red Blood Cells --during infancy D Ag^during infancy PrThr Pt RBC Ord D Ag infant RBC Ql
2019-11-07 93941-3 ABO and Rh group during infancy panel - Blood ABO & Rh group during infancy panel - Pt Bld - ABO+Rh Gp Pnl infant Bld
2019-11-07 93944-7 little c Ag [Presence] in Cord red blood cells little c Ag PrThr Pt RBCCo Ord little c Ag RBCCo Ql
2019-11-07 93945-4 E Ag [Presence] in Cord red blood cells E Ag PrThr Pt RBCCo Ord E Ag RBCCo Ql
2019-11-07 93946-2 C Ag [Presence] in Cord red blood cells C Ag PrThr Pt RBCCo Ord C Ag RBCCo Ql
2019-11-07 93948-8 D Ag [Presence] in Cord red blood cells D Ag PrThr Pt RBCCo Ord D Ag RBCCo Ql
2019-11-07 93949-6 ABO and Rh group panel - Cord blood ABO & Rh group panel - Pt BldCo - ABO + Rh Pnl BldCo
2019-11-07 93947-0 Rh antigens and K Ag panel - Cord blood Rh antigens & K Ag panel - Pt BldCo - Rh Ags+K Ag Pnl BldCo
2019-11-07 93950-4 D variant Ag [Presence] on Red Blood Cells D variant Ag PrThr Pt RBC Ord D Var Ag RBC Ql
2019-11-07 93952-0 Metamyelocytes.neutrophilic/100 leukocytes in Bone marrow by Manual count Metamyelocytes.neutrophilic/100 leukocytes NFr Pt Bone mar Qn Manual count Metamyelocytes.neut/leuk NFr Mar Manual
2019-11-07 93953-8 Villous lymphocytes [Presence] in Blood by Light microscopy Lymphocytes.villous PrThr Pt Bld Ord Microscopy.light Lymph Villous Bld Ql Smear
2019-11-07 93951-2 Rh antigens and K Ag panel - Blood Rh antigens & K Ag panel - Pt Bld - Rh Ags+K Ag Pnl Bld
2019-11-07 93954-6 Wound, Ostomy, and Continence Care Outpatient Note Note Find Pt Outpatient Doc Wound, ostomy, and continence care WOC OP Note
2019-11-07 93955-3 Wound, Ostomy, and Continence Care Consult note Consultation note Find Pt {Setting} Doc Wound, ostomy, and continence care WOC Consult note
2019-11-07 93958-7 Eating disorders Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Eating disorders Eating disorders Diag study note
2019-11-07 93957-9 Developmental-behavioral pediatrics Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Developmental-behavioral pediatrics Develop-behav peds Diag study note
2019-11-07 93956-1 Heart failure+Transplant cardiology Letter Letter Find Pt {Setting} Doc Heart failure+Transplant cardiology HF+TC Letter
2019-11-07 93960-3 Immunology Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Immunology Immunology Diag study note
2019-11-07 93961-1 Integrative medicine Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Integrative medicine Integrative medicine Diag study note
2019-11-07 93959-5 Heart failure+Transplant cardiology Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Heart failure+Transplant cardiology HF+TC Diag study note
2019-11-07 93962-9 Nephrology Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Nephrology Nephrology Diag study note
2019-11-07 93963-7 Pediatrics Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Pediatrics Peds Diag study note
2019-11-07 93964-5 Pharmacogenomics Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Pharmacogenomics Pharmacogenomics Diag study note
2019-11-07 93965-2 Physical medicine and rehab Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Physical medicine and rehab PM+R Diag study note
2019-11-07 93966-0 Plastic surgery Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Plastic surgery Plastic surgery Diag study note
2019-11-07 93967-8 Psychiatry Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Psychiatry Psychiatric Diag study note
2019-11-07 93968-6 Psychology Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Psychology Psych Diag study note
2019-11-07 93969-4 Trauma Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Trauma Trauma Diag study note
2019-11-07 93970-2 Wound, Ostomy, and Continence Care Diagnostic study note Diagnostic study note Find Pt {Setting} Doc Wound, ostomy, and continence care WOC Diag study note
2019-11-07 93971-0 Elevation climbed [Length/Time] 24 hour Elevation climbed LRat 24H ^Patient Qn Elevation climbed 24h lRate
2019-11-07 93972-8 Acetaminophen-cysteine adduct [Moles/volume] in Serum or Plasma Acetaminophen-cysteine adduct SCnc Pt Ser/Plas Qn APAP-Cysteine SerPl-sCnc
2019-11-07 93973-6 Iohexol [Mass/volume] in Urine Iohexol MCnc Pt Urine Qn Iohexol Ur-mCnc
2019-11-07 93974-4 Iohexol [Mass/volume] in Serum or Plasma Iohexol MCnc Pt Ser/Plas Qn Iohexol SerPl-mCnc
2019-11-07 93975-1 Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour specimen Urea nitrogen^1H specimen MCnc Pt Ser/Plas Qn BUN 1h spec SerPl-mCnc
2019-11-07 93976-9 Chikungunya virus Ab.IgM and IgG panel - Serum Qualitative Chikungunya virus Ab.IgM & IgG panel - Pt Ser Ord CHIKV IgG+IgM Pnl Ser
2019-11-07 93977-7 Complement C2.functional [Units/volume] in Serum or Plasma Complement C2.functional ACnc Pt Ser/Plas Qn C2.functional SerPl-aCnc
2019-11-07 93978-5 Complement C4.functional [Units/volume] in Serum or Plasma Complement C4.functional ACnc Pt Ser/Plas Qn C4.functional SerPl-aCnc
2019-11-07 93979-3 Chikungunya virus IgG Ab [Presence] in Serum Chikungunya virus Ab.IgG PrThr Pt Ser Ord CHIKV IgG Ser Ql
2019-11-07 93980-1 Iothalamate [Mass/volume] in Serum or Plasma Iothalamate MCnc Pt Ser/Plas Qn Iothalamate SerPl-mCnc
2019-11-07 93981-9 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --2 hours post dose carbohydrate Hydrogen/Expired gas^2H post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 2h p carb
2019-11-07 93982-7 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1.5 hours post dose carbohydrate Hydrogen/Expired gas^1.5H post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 1.5h p carb
2019-11-07 93983-5 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --1 hour post dose carbohydrate Hydrogen/Expired gas^1H post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 1h p carb
2019-11-07 93984-3 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --45 minutes post dose carbohydrate Hydrogen/Expired gas^45M post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 45M p carb
2019-11-07 93985-0 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --30 minutes post dose carbohydrate Hydrogen/Expired gas^30M post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 30M p carb
2019-11-07 93986-8 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --15 minutes post dose carbohydrate Hydrogen/Expired gas^15M post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 15M p carb
2019-11-07 93987-6 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --pre dose carbohydrate Hydrogen/Expired gas^pre dose carbohydrate VFr Pt Exhl gas Qn Breath H2 pre carb
2019-11-07 93988-4 Hydrogen/Expired gas [Volume Fraction] in Exhaled gas --post dose carbohydrate Hydrogen/Expired gas^post dose carbohydrate VFr Pt Exhl gas Qn Breath H2 p carb
2019-11-07 93989-2 Carbohydrate challenge panel - Exhaled gas Carbohydrate challenge panel - Pt Exhl gas - Carb chal Pnl ExG
2019-11-07 93990-0 Osmolality of Serum or Plasma--1 hour post fluid fast Osmolality^post 1H FFst Osmol Pt Ser/Plas Qn Osmolality p 1h FFST SerPl
2019-11-07 93991-8 Osmolality of Serum or Plasma--2 hours post fluid fast Osmolality^post 2H FFst Osmol Pt Ser/Plas Qn Osmolality p 2h FFST SerPl
2019-11-07 93992-6 Osmolality of Serum or Plasma--3 hours post fluid fast Osmolality^post 3H FFst Osmol Pt Ser/Plas Qn Osmolality p 3h FFST SerPl
2019-11-07 93993-4 Osmolality of Serum or Plasma--4 hours post fluid fast Osmolality^post 4H FFst Osmol Pt Ser/Plas Qn Osmolality p 4h FFST SerPl
2019-11-07 93994-2 Osmolality of Serum or Plasma--5 hours post fluid fast Osmolality^post 5H FFst Osmol Pt Ser/Plas Qn Osmolality p 5h FFST SerPl
2019-11-07 93995-9 Osmolality of Serum or Plasma--6 hours post fluid fast Osmolality^post 6H FFst Osmol Pt Ser/Plas Qn Osmolality p 6h FFST SerPl
2019-11-07 93996-7 Osmolality of Serum or Plasma--7 hours post fluid fast Osmolality^post 7H FFst Osmol Pt Ser/Plas Qn Osmolality p 7h FFST SerPl
2019-11-07 93997-5 Sodium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin Sodium^1H post dose vasopressin SCnc Pt Ser/Plas Qn Sodium 1h p Vaso SerPl-sCnc
2019-11-07 93998-3 Potassium [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin Potassium^1H post dose vasopressin SCnc Pt Ser/Plas Qn Potassium 1h p Vaso SerPl-sCnc
2019-11-07 93999-1 Creatinine [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin Creatinine^1H post dose vasopressin MCnc Pt Ser/Plas Qn Creat 1h p Vaso SerPl-mCnc
2019-11-07 94000-7 Chloride [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin Chloride^1H post dose vasopressin SCnc Pt Ser/Plas Qn Chloride 1h p Vaso SerPl-sCnc
2019-11-07 94001-5 Bicarbonate [Moles/volume] in Serum or Plasma --1 hour post dose vasopressin Bicarbonate^1H post dose vasopressin SCnc Pt Ser/Plas Qn HCO3 1h p Vaso SerPl-sCnc
2019-11-07 94002-3 Anion gap 3 in Serum or Plasma --1 hour post dose vasopressin Anion Gap 3^1H post dose vasopressin SCnc Pt Ser/Plas Qn Anion Gap3 1h p Vaso SerPl-sCnc
2019-11-07 94004-9 Osmolality of Serum or Plasma--1 hour post dose vasopressin Osmolality^1H post dose vasopressin Osmol Pt Ser/Plas Qn Osmolality 1h p Vaso SerPl
2019-11-07 94003-1 Urea nitrogen [Mass/volume] in Serum or Plasma --1 hour post dose vasopressin Urea nitrogen^1H post dose vasopressin MCnc Pt Ser/Plas Qn BUN 1h p Vaso SerPl-mCnc
2019-11-07 94005-6 Osmolality of Urine--1 hour post dose vasopressin Osmolality^1H post dose vasopressin Osmol Pt Urine Qn Osmolality 1h p Vaso Ur
2019-11-07 94006-4 Sodium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin Sodium^2H post dose vasopressin SCnc Pt Ser/Plas Qn Sodium 2h p Vaso SerPl-sCnc
2019-11-07 94007-2 Potassium [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin Potassium^2H post dose vasopressin SCnc Pt Ser/Plas Qn Potassium 2h p Vaso SerPl-sCnc
2019-11-07 94010-6 Bicarbonate [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin Bicarbonate^2H post dose vasopressin SCnc Pt Ser/Plas Qn HCO3 2h p Vaso SerPl-sCnc
2019-11-07 94011-4 Anion gap 3 in Serum or Plasma --2 hours post dose vasopressin Anion Gap 3^2H post dose vasopressin SCnc Pt Ser/Plas Qn Anion Gap3 2h p Vaso SerPl-sCnc
2019-11-07 94009-8 Chloride [Moles/volume] in Serum or Plasma --2 hours post dose vasopressin Chloride^2H post dose vasopressin SCnc Pt Ser/Plas Qn Chloride 2h p Vaso SerPl-sCnc
2019-11-07 94008-0 Creatinine [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin Creatinine^2H post dose vasopressin MCnc Pt Ser/Plas Qn Creat 2h p Vaso SerPl-mCnc
2019-11-07 94013-0 Osmolality of Serum or Plasma--2 hours post dose vasopressin Osmolality^2H post dose vasopressin Osmol Pt Ser/Plas Qn Osmolality 2h p Vaso SerPl
2019-11-07 94014-8 Osmolality of Urine--2 hours post dose vasopressin Osmolality^2H post dose vasopressin Osmol Pt Urine Qn Osmolality 2h p Vaso Ur
2019-11-07 94012-2 Urea nitrogen [Mass/volume] in Serum or Plasma --2 hours post dose vasopressin Urea nitrogen^2H post dose vasopressin MCnc Pt Ser/Plas Qn BUN 2h p Vaso SerPl-mCnc
2019-11-07 94015-5 Mental health screening report Mental health screening report Find Pt ^Patient Doc MH screen report
2019-11-07 94018-9 ADHD screening report ADHD screening report Find Pt ^Patient Doc ADHD screen report
2019-11-07 94016-3 Depression screening report Depression screening report Find Pt ^Patient Doc Depression screen report
2019-11-07 94017-1 Anxiety screening report Anxiety screening report Find Pt ^Patient Doc Anxiety screen report
2019-11-07 94020-5 Somatic symptom disorder screening report Somatic symptom disorder screening report Find Pt ^Patient Doc SSD screen report
2019-11-07 94019-7 Bipolar screening report Bipolar screening report Find Pt ^Patient Doc Bipolar screen report
2019-11-07 94021-3 Substance use disorder screening report Substance use disorder screening report Find Pt ^Patient Doc SUD screen report
2019-11-07 94022-1 Depression score Depression score Score Pt ^Patient Qn Depression score
2019-11-07 94023-9 Depression severity Depression severity Imp Pt ^Patient Ord Depression severity
2019-11-07 94024-7 Anxiety score Anxiety score Score Pt ^Patient Qn Anxiety score
2019-11-07 94025-4 Anxiety severity Anxiety severity Imp Pt ^Patient Ord Anxiety severity
2019-11-07 94026-2 Bipolar disorder type Bipolar disorder type Type Pt ^Patient Nom Bipolar type
2019-11-07 94027-0 Somatic symptom disorder score Somatic symptom disorder score Score Pt ^Patient Qn SSD score
2019-11-07 94028-8 Somatic symptom disorder severity Somatic symptom disorder severity Imp Pt ^Patient Ord SSD severity
2019-11-07 94029-6 Substance use disorder score Substance use disorder score Score Pt ^Patient Qn SUD score
2019-11-07 94030-4 Substance use disorder severity Substance use disorder severity Imp Pt ^Patient Ord SUD severity
2019-11-07 94031-2 ADHD type ADHD type Type Pt ^Patient Nom ADHD type
2019-11-07 94032-0 ADHD inattentive symptoms severity ADHD inattentive symptoms severity Imp Pt ^Patient Ord ADHD inattentive severity
2019-11-07 94033-8 ADHD hyperactive symptoms severity ADHD hyperactive symptoms severity Imp Pt ^Patient Ord ADHD hyperactive severity
2019-11-07 94034-6 Suicidal intent Suicidal intent Find Pt ^Patient Ord Suicidal intent
2019-11-07 94035-3 Suicide plan Suicide plan Find Pt ^Patient Ord Suicide plan
2019-11-07 94036-1 Suicide risk factor Suicide risk factor Find Pt ^Patient Nom Suicide risk factor
2019-11-07 94037-9 Suicidal ideation Suicidal ideation Find Pt ^Patient Nom Suicidal ideation
2019-11-07 94038-7 Substance use disorder question consistency score Substance use disorder question consistency score Score Pt ^Patient Qn SUD consistency score
2019-11-07 94039-5 ADHD question consistency score ADHD question consistency score Score Pt ^Patient Qn ADHD consistency score
2019-11-07 94040-3 Adenovirus A+B+C+D+E DNA [Presence] in Respiratory specimen by NAA with probe detection Adenovirus A+B+C+D+E DNA PrThr Pt Respiratory Ord Probe.amp.tar HAdV A+B+C+D+E DNA Resp Ql NAA+probe
2019-11-07 94041-1 My practice makes it easy for me to get care [PCPCM] My practice makes it easy for me to get care Find Pt ^Patient Ord PCPCM
2019-11-07 94044-5 My practice coordinates the care I get from multiple places [PCPCM] My practice coordinates the care I get from multiple places Find Pt ^Patient Ord PCPCM
2019-11-07 94042-9 My practice is able to provide most of my care [PCPCM] My practice is able to provide most of my care Find Pt ^Patient Ord PCPCM
2019-11-07 94043-7 In caring for me, my doctor considers all the factors that affect my health [PCPCM] In caring for me, my doctor considers all the factors that affect my health Find Pt ^Patient Ord PCPCM
2019-11-07 94045-2 My doctor or practice knows me as a person [PCPCM] My doctor or practice knows me as a person Find Pt ^Patient Ord PCPCM
2019-11-07 94046-0 My doctor and I have been through a lot together [PCPCM] My doctor and I have been through a lot together Find Pt ^Patient Ord PCPCM
2019-11-07 94047-8 My doctor or practice stands up for me [PCPCM] My doctor or practice stands up for me Find Pt ^Patient Ord PCPCM
2019-11-07 94048-6 The care I get takes into account knowledge of my family [PCPCM] The care I get takes into account knowledge of my family Find Pt ^Patient Ord PCPCM
2019-11-07 94051-0 Over time, my practice helps me to meet my goals [PCPCM] Over time, my practice helps me to meet my goals Find Pt ^Patient Ord PCPCM
2019-11-07 94050-2 Over time, my practice helps me to stay healthy [PCPCM] Over time, my practice helps me to stay healthy Find Pt ^Patient Ord PCPCM
2019-11-07 94049-4 The care I get in this practice is informed by knowledge of my community [PCPCM] The care I get in this practice is informed by knowledge of my community Find Pt ^Patient Ord PCPCM
2019-11-07 94052-8 Mean score [PCPCM] Mean score Score Pt ^Patient Qn PCPCM
2019-11-06 93842-3 HOGA1 gene full mutation analysis in Blood or Tissue by Sequencing HOGA1 gene full mutation analysis Find Pt Bld/Tiss Doc Sequencing HOGA1 Full Mut Anl Bld/T Seq
2019-11-06 93843-1 Primary hyperoxaluria multigene analysis in Blood or Tissue by Molecular genetics method Primary hyperoxaluria multigene analysis Find Pt Bld/Tiss Doc Molgen PH Multigene Anl Bld/T
2019-11-06 93844-9 UGT1A1 gene full mutation analysis in Blood or Tissue by Sequencing UGT1A1 gene full mutation analysis Find Pt Bld/Tiss Doc Sequencing UGT1A1 gene Full Mut Anl Bld/T Seq
2019-11-06 93845-6 UGT1A1 gene TA repeats and c.211G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal UGT1A1 gene.TA repeats & c.211G>A Geno Pt Bld/Tiss Nom Molgen UGT1A1 TA + c.211G>A Geno Bld/T
2019-11-06 93846-4 Hemoglobin [Moles/volume] in Venous blood Hemoglobin SCnc Pt BldV Qn Hgb BldV-sCnc
2019-11-06 93847-2 Aspergillus oryzae IgE Ab [Units/volume] in Serum Aspergillus oryzae Ab.IgE ACnc Pt Ser Qn A oryzae IgE Qn
2019-11-06 93848-0 Setting of exposure to environmental or occupational hazard Setting of exposure to environmental or occupational hazard Type Pt ^Patient Nom Set of hazard exposure
2019-11-06 93849-8 Exercise distance in 24 hour Exercise distance Len 24H ^Patient Qn Exercise distance 24h
2019-11-06 93850-6 Pretomanid [Susceptibility] Pretomanid Susc Pt Isolate OrdQn Pretomanid Susc Islt
2019-11-06 93851-4 Delamanid [Susceptibility] Delamanid Susc Pt Isolate OrdQn Delamanid Susc Islt
2019-11-06 93852-2 N-Acetylgalactosamine-4-Sulfatase/N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity ratio] in Urine N-acetylgalactosamine-4-sulfatase/N-acetylgalactosamine-6-sulfatase CRto Pt Urine Qn Arylsulfatase B/GALNS Ur-cRto
2019-11-06 93853-0 N-Acetylgalactosamine-6-Sulfatase [Enzymatic activity/volume] in Urine N-Acetylgalactosamine-6-Sulfatase CCnc Pt Urine Qn GALNS Ur-cCnc
2019-11-06 93854-8 Gadolinium/Creatinine [Mass Ratio] in Urine Gadolinium/Creatinine MRto Pt Urine Qn Gadolinium/Creat Ur
2019-11-06 93855-5 Iothalamate [Mass/volume] in Urine Iothalamate MCnc Pt Urine Qn Iothalamate Ur-mCnc
2019-11-06 93856-3 Enterovirus RNA [Presence] in Unspecified specimen by NAA with non-probe detection Enterovirus RNA PrThr Pt XXX Ord Non-probe.amp.tar EV RNA XXX Ql NAA+non-probe
2019-11-06 93857-1 Date and time of obstetric delivery Date and time of obstetric delivery TmStp Pt ^Patient Qn Date+time OB delivery
2019-11-06 93859-7 Toxoplasma gondii IgG Ab [Presence] in Serum from Donor by Immunoassay Toxoplasma gondii Ab.IgG PrThr Pt Ser^Donor Ord IA T gondii IgG Ser Donr Ql IA
2019-11-06 93858-9 Toxoplasma gondii IgG panel - Serum from Donor Toxoplasma gondii Ab.IgG panel - Pt Ser^Donor - T gondii IgG pnl Ser Donr
2019-11-06 93860-5 Toxoplasma gondii IgG Ab [Units/volume] in Serum from Donor by Immunoassay Toxoplasma gondii Ab.IgG ACnc Pt Ser^Donor Qn IA T gondii IgG Ser Donr IA-aCnc
2019-11-06 93861-3 Temperature Veterinary cage Temperature Temp Pt Veterinary cage Qn Temp Vet cage
2019-11-06 93862-1 Temperature setting Veterinary cage Temperature setting Temp Pt Veterinary cage Qn Temp setting Vet cage
2019-11-06 93863-9 Oxygen/Gas total Veterinary cage Oxygen/Gas.total VFr Pt Veterinary cage Qn O2/Gas.total VFr Vet cage
2019-11-06 93864-7 Oxygen gas setting Veterinary cage Oxygen gas setting VFr Pt Veterinary cage Qn O2 set VFr Vet cage
2019-11-06 93865-4 General medicine Team Conference note Conference note Find Pt {Setting} Doc General medicine.team Gen med Team Conf eval note
2019-11-06 93866-2 C4 nephritic factor [Presence] in Serum or Plasma C4 nephritic factor PrThr Pt Ser/Plas Ord C4 NeF SerPl Ql
2019-11-06 93867-0 GABABR Ab [Presence] in Serum by Cell binding assay immunofluorescent assay Gamma aminobutyrate B receptor Ab PrThr Pt Ser Ord CBA IFA GABABR Ab Ser Ql CBA IFA
2019-11-06 93868-8 AMPAR2 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab PrThr Pt Ser Ord CBA IFA AMPAR2 Ab Ser Ql CBA IFA
2019-11-06 93869-6 AMPAR1 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 1 Ab PrThr Pt Ser Ord CBA IFA AMPAR1 Ab Ser Ql CBA IFA
2019-11-06 93870-4 NMDAR subunit 1 Ab [Presence] in Serum by Cell binding assay immunofluorescent assay N-methyl-D-aspartate receptor subunit 1 Ab PrThr Pt Ser Ord CBA IFA NMDAR1 Ab Ser Ql CBA IFA
2019-11-05 93795-3 NOP56 gene GGCCTG repeats [Presence] in Blood or Tissue by Molecular genetics method NOP56 gene.GGCCTG repeats PrThr Pt Bld/Tiss Ord Molgen NOP56 GGCCTG repeats Bld/T Ql
2019-11-05 93796-1 MYCN gene amplification in Tissue by FISH MYCN gene amplification Find Pt Tiss Doc FISH MYCN amplification Tiss FISH
2019-11-05 93797-9 MYCN gene copy number/Chromosome 2 copy number in Tissue by FISH MYCN gene copy number/Chromosome 2 copy number NRto Pt Tiss Qn FISH MYCN copy num/Chr 2 copy num Tiss FISH
2019-11-05 93798-7 MYCN gene copy number/nucleus in Tissue by FISH MYCN gene copy number/nucleus EntNum Pt Tiss Qn FISH MYCN copy num/nucleus EntNum Tiss FISH
2019-11-05 93799-5 Chromosome 2 copy number/nucleus in Tissue by FISH Chromosome 2 copy number/nucleus EntNum Pt Tiss Qn FISH Chr 2 copy num/nucleus EntNum Tiss FISH
2019-11-05 93801-9 Chromosome 1 polysomy [Presence] in Tissue by FISH Chromosome 1 polysomy PrThr Pt Tiss Ord FISH Chr 1 polysomy Tiss Ql FISH
2019-11-05 93800-1 1p/1q chromosome deletion [# Ratio] in Tissue by FISH 1p chromosome deletion/1q chromosome deletion NRto Pt Tiss Qn FISH 1p/1q Chrom Del Tiss FISH
2019-11-05 93804-3 Chromosome 12 copy number/nucleus in Tissue by FISH Chromosome 12 copy number/nucleus EntNum Pt Tiss Qn FISH Chr 12 copy num/nucleus EntNum Tiss FISH
2019-11-05 93803-5 Chromosome 19 polysomy [Presence] in Tissue by FISH Chromosome 19 polysomy PrThr Pt Tiss Ord FISH Chr 19 polysomy Tiss Ql FISH
2019-11-05 93805-0 MDM2 gene copy number/nucleus in Tissue by FISH MDM2 gene copy number/nucleus EntNum Pt Tiss Qn FISH MDM2 copy num/nucleus EntNum Tiss FISH
2019-11-05 93802-7 19q/19p chromosome deletion [# Ratio] in Tissue by FISH 19q chromosome deletion/19p chromosome deletion NRto Pt Tiss Qn FISH 19q/19p Chrom Del Tiss FISH
2019-11-05 93806-8 EWSR1 gene rearrangements in Tissue by FISH EWSR1 gene rearrangements Find Pt Tiss Doc FISH EWSR1 gene Rear Tiss FISH
2019-11-05 93807-6 FOXO1 gene rearrangements in Tissue by FISH FOXO1 gene rearrangements Find Pt Tiss Doc FISH FOXO1 gene Rear Tiss FISH
2019-11-05 93808-4 MDM2 gene amplification in Tissue by FISH MDM2 gene amplification Find Pt Tiss Doc FISH MDM2 amplification Tiss FISH
2019-11-05 93809-2 MDM2 gene copy number/Chromosome 12 copy number in Tissue by FISH MDM2 gene copy number/Chromosome 12 copy number NRto Pt Tiss Qn FISH MDM2 copy num/Chr 12 copy num Tiss FISH
2019-11-05 93810-0 SS18 gene rearrangements in Tissue by FISH SS18 gene rearrangements Find Pt Tiss Doc FISH SS18 gene Rear Tiss FISH
2019-11-05 93811-8 F9 gene full mutation analysis in Blood or Tissue by Sequencing F9 gene full mutation analysis Find Pt Bld/Tiss Doc Sequencing F9 gene Full Mut Anl Bld/T Seq
2019-11-05 93812-6 1,3 beta glucan [Presence] in Serum 1,3 beta glucan PrThr Pt Ser Ord 1,3 beta glucan Ser Ql
2019-11-05 93813-4 NTRK1, NTRK2 and NTRK3 gene rearrangements in Tissue by Molecular genetics method NTRK1 gene & NTRK2 gene & NTRK3 gene rearrangements Find Pt Tiss Doc Molgen NTRK1+NTRK2+NTRK3 rearr Tiss
2019-11-05 93814-2 SERPINC1 gene full mutation analysis in Blood or Tissue by Sequencing SERPINC1 gene full mutation analysis Find Pt Bld/Tiss Doc Sequencing SERPINC1 gene Full Mut Anl Bld/T Seq
2019-11-05 93815-9 PROC gene full mutation analysis in Blood or Tissue by Sequencing PROC gene full mutation analysis Find Pt Bld/Tiss Doc Sequencing PROC Full Mut Anl Bld/T Seq
2019-11-05 93818-3 Cycling distance unspecified time Cycling distance Len XXX ^Patient Qn Cycle distance ?Tm
2019-11-05 93819-1 Calories burned in unspecified time --during activity Calories burned^during activity EngRat XXX ^Patient Qn Calories burned dur activity ?Tm
2019-11-05 93817-5 Running distance unspecified time Running distance Len XXX ^Patient Qn Run distance ?Tm
2019-11-05 93816-7 Swimming distance unspecified time Swimming distance Len XXX ^Patient Qn Swim distance ?Tm
2019-11-05 93821-7 Calories burned in unspecified time --during aerobic activity Calories burned^during aerobic activity EngRat XXX ^Patient Qn Calories burned dur aerobic activity ?Tm
2019-11-05 93822-5 Calories burned in unspecified time --while playing a sport Calories burned^while playing a sport EngRat XXX ^Patient Qn Calories burned playing a sport ?Tm
2019-11-05 93820-9 Calories burned in unspecified time --during weight training Calories burned^during weight training EngRat XXX ^Patient Qn Calories burned dur wght training ?Tm
2019-11-05 93825-8 Calories burned in unspecified time --during running Calories burned^during running EngRat XXX ^Patient Qn Calories burned dur running ?Tm
2019-11-05 93826-6 Calories burned in unspecified time --during walking Calories burned^during walking EngRat XXX ^Patient Qn Calories burned dur walking ?Tm
2019-11-05 93824-1 Calories burned in unspecified time --during cycling Calories burned^during cycling EngRat XXX ^Patient Qn Calories burned dur cycle ?Tm
2019-11-05 93823-3 Calories burned in unspecified time --during swimming Calories burned^during swimming EngRat XXX ^Patient Qn Calories burned dur swim ?Tm
2019-11-05 93828-2 Nighttime awakening duration Nighttime awakening duration Time Pt ^Patient Qn Nighttime awake duration
2019-11-05 93829-0 REM sleep duration REM sleep duration Time Pt ^Patient Qn REM sleep duration
2019-11-05 93827-4 Nighttime awakening Nighttime awakening Num Pt ^Patient Qn Nighttime awaken
2019-11-05 93830-8 Light sleep duration Light sleep duration Time Pt ^Patient Qn Light sleep duration
2019-11-05 93831-6 Deep sleep duration Deep sleep duration Time Pt ^Patient Qn Deep sleep duration
2019-11-05 93832-4 Sleep duration Sleep duration Time Pt ^Patient Qn Sleep duration
2019-11-05 93833-2 Flights climbed 24 hour Flights climbed NRat 24H ^Patient Qn Flights climbed 24h nRate
2019-11-05 93834-0 Coccidioides sp IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay Coccidioides sp Ab.IgM ACnc Pt CSF Qn IA Coccidioides IgM CSF IA-aCnc
2019-11-05 93835-7 Coccidioides sp IgM Ab [Units/volume] in Serum or Plasma by Immunoassay Coccidioides sp Ab.IgM ACnc Pt Ser/Plas Qn IA Coccidioides IgM SerPl IA-aCnc
2019-11-05 93836-5 Coccidioides sp IgG Ab [Units/volume] in Serum or Plasma by Immunoassay Coccidioides sp Ab.IgG ACnc Pt Ser/Plas Qn IA Coccidioides IgG SerPl IA-aCnc
2019-11-05 93837-3 Coccidioides sp IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay Coccidioides sp Ab.IgG ACnc Pt CSF Qn IA Coccidioides IgG CSF IA-aCnc
2019-11-05 93838-1 Histoplasma capsulatum IgM Ab [Units/volume] in Cerebral spinal fluid by Immunoassay Histoplasma capsulatum Ab.IgM ACnc Pt CSF Qn IA H capsul IgM CSF IA-aCnc
2019-11-05 93839-9 Histoplasma capsulatum IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay Histoplasma capsulatum Ab.IgG ACnc Pt CSF Qn IA H capsul IgG CSF IA-aCnc
2019-11-05 93840-7 Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection Epstein Barr virus DNA ACnc Pt Bld Qn Probe.amp.tar EBV DNA Bld NAA+probe-aCnc
2019-11-05 93841-5 Epstein Barr virus DNA [log units/volume] (viral load) in Blood by NAA with probe detection Epstein Barr virus DNA LaCnc Pt Bld Qn Probe.amp.tar EBV DNA Bld NAA+probe-Log IU
2019-11-04 93724-3 Keratan sulfate [Mass/volume] in Serum or Plasma Keratan sulfate MCnc Pt Ser/Plas Qn Keratan Sulfate SerPl-mCnc
2019-11-04 93725-0 Heparan sulfate [Mass/volume] in Serum or Plasma Heparan sulfate MCnc Pt Ser/Plas Qn Heparan sulfate SerPl-mCnc
2019-11-04 93726-8 Dermatan sulfate and heparan sulfate and keratan sulfate panel - Serum or Plasma Dermatan sulfate & heparan sulfate & keratan sulfate panel - Pt Ser/Plas - MPS panel SerPl
2019-11-04 93727-6 Insulin [Moles/volume] in Serum or Plasma --post meal Insulin^post meal SCnc Pt Ser/Plas Qn Insulin p meal SerPl-sCnc
2019-11-04 93731-8 Androstenedione [Moles/volume] in Amniotic fluid Androstenedione SCnc Pt Amnio fld Qn Androst Amn-sCnc
2019-11-04 93730-0 Testosterone [Moles/volume] in Amniotic fluid Testosterone SCnc Pt Amnio fld Qn Testost Amn-sCnc
2019-11-04 93728-4 Copper [Moles/volume] in Dialysis fluid Copper SCnc Pt Dial fld Qn Copper Dial fld-sCnc
2019-11-04 93729-2 Beta-2-Microglobulin/Creatinine [Ratio] in 24 hour Urine Beta-2-Microglobulin/Creatinine Ratio 24H Urine Qn B2 Microglob/Creat 24h Ur-Rto
2019-11-04 93732-6 IgE [Units/volume] in Tear IgE ACnc Pt Tear Qn IgE Tear-aCnc
2019-11-04 93733-4 Creatinine [Mass/time] in 5 hour Urine Creatinine MRat 5H Urine Qn Creat 5h Ur-mRate
2019-11-04 93734-2 Creatinine [Moles/time] in 5 hour Urine Creatinine SRat 5H Urine Qn Creat 5h Ur-sRate
2019-11-04 93735-9 Creatinine [Moles/volume] in 5 hour Urine Creatinine SCnc 5H Urine Qn Creat 5h Ur-sCnc
2019-11-04 93736-7 Creatinine panel - 5 hour Urine Creatinine panel - 5H Urine - Creat Pnl Ur
2019-11-04 93737-5 German turnip IgE Ab [Units/volume] in Serum Brassica oleracea var gongylodes Ab.IgE ACnc Pt Ser Qn German turnip IgE Qn
2019-11-04 93738-3 Cooked cauliflower IgE Ab [Units/volume] in Serum Brassica oleracea var botrytis cooked Ab.IgE ACnc Pt Ser Qn Cooked cauliflower IgE Qn
2019-11-04 93739-1 Red cabbage IgE Ab [Units/volume] in Serum Brassica oleracea var capitata f rubra Ab.IgE ACnc Pt Ser Qn Red cabbage IgE Qn
2019-11-04 93740-9 Chives IgE Ab [Units/volume] in Serum Allium schoenoprasum Ab.IgE ACnc Pt Ser Qn Chives IgE Qn
2019-11-04 93741-7 Balm IgE Ab [Units/volume] in Serum Melissa officinalis Ab.IgE ACnc Pt Ser Qn Balm IgE Qn
2019-11-04 93742-5 HTLV I and II Ab band pattern [Interpretation] in Cerebral spinal fluid by Line blot HTLV I & II Ab band pattern Imp Pt CSF Nom Line blot HTLV I+II Ab Patrn CSF Line blot-Imp
2019-11-04 93743-3 HTLV I and II IgG band [Type] in Cerebral spinal fluid by Line blot HTLV I & II Ab.IgG band Type Pt CSF Nom Line blot HTLV I + II ab band CSF Line blot
2019-11-04 93744-1 HTLV I and II IgG panel - Cerebral spinal fluid HTLV I & II Ab.IgG panel - Pt CSF - HTLV I+II IgG Pnl CSF
2019-11-04 93745-8 HTLV I+II IgG Ab [Presence] in Cerebral spinal fluid by Line blot HTLV I+II Ab.IgG PrThr Pt CSF Ord Line blot HTLV I+II IgG CSF Ql Line blot
2019-11-04 93746-6 Protein catabolic rate based on 24 hour Urine [Calculated] Protein catabolic rate MRat 24H Urine Qn Protein catabolic rate 24h Ur-mRate
2019-11-04 93747-4 Parainfluenza virus 1+2+3+4 IgG Ab [Presence] in Serum by Immunoassay Parainfluenza virus 1+2+3+4 Ab.IgG PrThr Pt Ser Ord IA HPIV 1+2+3+4 IgG Ser Ql IA
2019-11-04 93748-2 Fibrin monomer [Mass/volume] in Platelet poor plasma by Immunoassay Fibrin monomer MCnc Pt PPP Qn IA Fibrin Monomer PPP IA-mCnc
2019-11-04 93749-0 Mumps virus N gene [Cycle Threshold #] in Unspecified specimen by NAA with probe detection Mumps virus N gene ThreshNum Pt XXX Qn Probe.amp.tar MuV N gene Ct XXX Qn NAA+probe
2019-11-04 93750-8 Mumps virus RNA and N gene panel - Unspecified specimen Mumps virus RNA & N gene panel - Pt XXX - MuV RNA and N gene Pnl XXX
2019-11-04 93753-2 Porcine cytomegalovirus DNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection Porcine cytomegalovirus DNA ThreshNum Pt XXX Qn Probe.amp.tar PCMV DNA Ct XXX Qn NAA+probe
2019-11-04 93751-6 Atypical porcine pestivirus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection Atypical porcine pestivirus RNA ThreshNum Pt XXX Qn Probe.amp.tar APPV RNA Ct XXX Qn NAA+probe
2019-11-04 93752-4 Atypical porcine pestivirus RNA [#/volume] (viral load) in Unspecified specimen by NAA with probe detection Atypical porcine pestivirus RNA NCnc Pt XXX Qn Probe.amp.tar APPV RNA # XXX NAA+probe
2019-11-04 93754-0 Encephalomyocarditis virus RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection Encephalomyocarditis virus RNA ThreshNum Pt XXX Qn Probe.amp.tar EMCV RNA Ct XXX Qn NAA+probe
2019-11-04 93755-7 Porcine circovirus type 3 DNA [Presence] in Unspecified specimen by NAA with probe detection Porcine circovirus type 3 DNA PrThr Pt XXX Ord Probe.amp.tar PCV3 DNA XXX Ql NAA+probe
2019-11-04 93756-5 Mycoplasma hyorhinis IgG Ab/Positive control in Serum by Immunoassay Mycoplasma hyorhinis Ab.IgG/Positive control RelRto Pt Ser Qn IA M hyorhinis IgG/Pos cntrl Ser IA
2019-11-04 93757-3 Salmonella choleraesuis+infantis+typhimurium Ab/Positive control in Unspecified specimen by Immunoassay Salmonella choleraesuis+infantis+typhimurium Ab/Positive control RelRto Pt XXX Qn IA S chol+inf+typhimur Ab/Pos cntrl XXX IA
2019-11-04 93760-7 Influenza virus A PB1 gene [Nucleotide sequence] in Isolate by Sequencing Influenza virus A PB1 gene Seq Pt Isolate Nom Sequencing FLUAV PB1 gene Islt-Seq
2019-11-04 93758-1 Erysipelothrix sp [Presence] in Tissue by Organism specific culture Erysipelothrix sp PrThr Pt Tiss Ord Organism specific culture Erysipelothrix sp Tiss Ql Cult
2019-11-04 93759-9 Influenza virus A PB2 gene [Nucleotide sequence] in Isolate by Sequencing Influenza virus A PB2 gene Seq Pt Isolate Nom Sequencing FLUAV PB2 gene Islt-Seq
2019-11-04 93761-5 Influenza virus A PA gene [Nucleotide sequence] in Isolate by Sequencing Influenza virus A PA gene Seq Pt Isolate Nom Sequencing FLUAV PA gene Islt-Seq
2019-11-04 93762-3 Influenza virus A NP gene [Nucleotide sequence] in Isolate by Sequencing Influenza virus A NP gene Seq Pt Isolate Nom Sequencing FLUAV NP gene Islt-Seq
2019-11-04 93763-1 Influenza virus A NS1 gene [Nucleotide sequence] in Isolate by Sequencing Influenza virus A NS1 gene Seq Pt Isolate Nom Sequencing FLUAV NS1 gene Islt-Seq
2019-11-04 93764-9 Porcine astrovirus type 3 RNA [Cycle Threshold #] in Unspecified specimen by NAA with probe detection Porcine astrovirus type 3 RNA ThreshNum Pt XXX Qn Probe.amp.tar PoAstV3 RNA Ct XXX Qn NAA+probe
2019-11-04 93765-6 Trimethylamine N-oxide [Molar amount] in Serum Trimethylamine N-oxide Sub Pt Ser Qn TMAO sub Ser Qn
2019-11-04 93766-4 Cryptococcus sp Ag [Titer] in Urine by Rapid immunoassay Cryptococcus sp Ag Titr Pt Urine Qn IA.rapid Cryptoc Ag Titr Ur IA.rapid
2019-11-04 93767-2 Eravacycline [Susceptibility] by Gradient strip Eravacycline Susc Pt Isolate OrdQn Gradient strip Eravacycline Islt Grad strip
2019-11-04 93768-0 Acarboxyprothrombin [Units/volume] in Serum or Plasma Acarboxyprothrombin ACnc Pt Ser/Plas Qn Acarboxyprothrombin SerPl-aCnc
2019-11-04 93769-8 Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma Choriogonadotropin.intact+Beta subunit MCnc Pt Ser/Plas Qn HGC Intact+B SerPl-mCnc
2019-11-04 93770-6 Ceramide trihexoside [Molar ratio] in Urine Ceramide trihexoside SRto Pt Urine Qn Ceramide Trihexoside Ur-sRto
2019-11-04 93771-4 Calprotectin [Mass/volume] in Synovial fluid Calprotectin MCnc Pt Synv fld Qn Calprotectin Snv-mCnc
2019-11-04 93773-0 11-Deoxycortisol [Moles/volume] in Saliva (oral fluid) 11-Deoxycortisol SCnc Pt Saliva Qn 11DC Sal-sCnc
2019-11-04 93772-2 4-hydroxyglutamate/Creatinine [Molar ratio] in Urine 4-hydroxyglutamate/Creatinine SRto Pt Urine Qn 4OHGlu/Creat Ur-sRto
2019-11-04 93775-5 2-Octenoate/Creatinine [Molar ratio] in Urine 2-Octenoate/Creatinine SRto Pt Urine Qn 2-Octenoate/Creat Ur-sRto
2019-11-04 93774-8 Trans-cinnamoylglycine/Creatinine [Molar ratio] in Urine Trans-cinnamoylglycine/Creatinine SRto Pt Urine Qn tr-Cinnamoylgly/Creat Ur-sRto
2019-11-04 93776-3 Babesia duncani IgG Ab [Titer] in Serum by Immunofluorescence Babesia duncani Ab.IgG Titr Pt Ser Qn IF B duncani IgG Titr Ser IF
2019-11-04 93777-1 Human papilloma virus 16+18 E6+E7 mRNA [Presence] in Tissue by Probe Human papilloma virus 16+18 E6+E7 mRNA PrThr Pt Tiss Ord Probe HPV16+18 E6+E7 mRNA Tiss Ql Probe
2019-11-04 93778-9 Human papilloma virus 6+11 E6+E7 mRNA [Presence] in Tissue by Probe Human papilloma virus 6+11 E6+E7 mRNA PrThr Pt Tiss Ord Probe HPV6+11 E6+E7 mRNA Tiss Ql Probe
2019-11-04 93779-7 Large B-cell lymphoma and cell of origin [Type] in Tissue Large B-cell lymphoma and cell of origin Type Pt Tiss Nom Lg B-cell lymph+COO Tiss
2019-11-04 93780-5 Primary mediastinal large B-cell lymphoma [Likelihood] in Tissue Primary mediastinal large B-cell lymphoma Likelihood Pt Tiss Qn Prim Med Lg B-cell lymph Tiss
2019-11-04 93781-3 Diffuse large B-cell lymphoma.activated B-cell subtype [Likelihood] in Tissue Diffuse large B-cell lymphoma.activated B-cell subtype Likelihood Pt Tiss Qn Diff Lg B-cell Lymph.ABC Tiss
2019-11-04 93782-1 Large B-cell lymphoma [Type] in Tissue Large B-cell lymphoma Type Pt Tiss Nom Lg B-cell lymph Tiss
2019-11-04 93783-9 Diffuse large B-cell lymphoma cell of origin [Type] in Tissue Diffuse large B-cell lymphoma cell of origin Type Pt Tiss Nom Diff Lg B-cell lymph COO Tiss
2019-11-04 93784-7 Diffuse large B-Cell lymphoma cell of origin subclassification panel - Tissue Diffuse large B-Cell lymphoma cell of origin subclassification panel - Pt Tiss - Diff lg B-cell Lymph COO Pnl Tiss
2019-11-04 93785-4 Large B-cell lymphoma classification panel - Tissue Large B-cell lymphoma classification panel - Pt Tiss - Lg B-cell Lymph Pnl Tiss
2019-11-04 93786-2 Varicella zoster virus Ab.IgM+total [Presence] in Cerebral spinal fluid Varicella zoster virus Ab.IgM+total PrThr Pt CSF Ord VZV Ab.IgM+total CSF Ql
2019-11-04 93787-0 Lymphocytic choriomeningitis virus IgG+IgM Ab [Presence] in Cerebral spinal fluid Lymphocytic choriomeningitis virus Ab.IgG+IgM PrThr Pt CSF Ord LCMV IgG+IgM CSF Ql
2019-11-04 93788-8 F5 gene HR2 haplotype [Genotype] in Blood by Molecular genetics method Nominal F5 gene HR2 haplotype Geno Pt Bld Nom Molgen F5 HR2 Geno Bld
2019-11-04 93789-6 Time to microorganism growth detection in Specimen Time to microorganism growth detection Time * Specimen Qn Micro Detect Tm Spec
2019-11-04 93790-4 Delafloxacin [Susceptibility] by Gradient strip Delafloxacin Susc Pt Isolate OrdQn Gradient strip DLX Islt Grad strip
2019-11-04 93791-2 Glucose [Mass/volume] mean in Serum or Plasma Glucose MCnc Stdy^mean Ser/Plas Qn Glucose Mean SerPl-mCnc
2019-11-04 93792-0 Insulin sensitivity index in Serum or Plasma by calculation Insulin sensitivity index Ratio Pt Ser/Plas Qn Calculated Ins Sens Index SerPl Calc-Rto
2019-11-04 93793-8 Insulin [Units/volume] mean in Serum or Plasma Insulin ACnc Stdy^mean Ser/Plas Qn Insulin Mean SerPl-aCnc
2019-11-04 93794-6 Glucose tolerance and insulin sensitivity 2 hour panel - Serum or Plasma Glucose tolerance & insulin sensitivity 2H panel - - Ser/Plas - GTT ISI 2h Pnl SerPl
2019-11-01 93719-3 traMADol [Presence] in Meconium by Screen method traMADol PrThr Pt Meconium Ord Screen traMADol Mec Ql Scn
2019-11-01 93720-1 traMADol [Mass/mass] in Meconium by Confirmatory method traMADol MCnt Pt Meconium Qn Confirm traMADol Mec Cfm-mCnt
2019-11-01 93721-9 O-nortramadol [Mass/mass] in Meconium by Confirmatory method O-Nortramadol MCnt Pt Meconium Qn Confirm O-nortramadol Mec Cfm-mCnt
2019-11-01 93722-7 N-nortramadol [Mass/mass] in Meconium by Confirmatory method N-Nortramadol MCnt Pt Meconium Qn Confirm N-nortramadol Mec Cfm-mCnt
2019-11-01 93723-5 FDA product label Indexing - drug interactions Indexing - drug interactions - - ^FDA product label Nar FDA label Index - drug interactions
2019-10-30 93691-4 Nonalcoholic steatohepatitis and fibrosis panel - Serum or Plasma Nonalcoholic steatohepatitis & fibrosis panel - Pt Ser/Plas - NASH + fibrosis Pnl SerPl
2019-10-30 93692-2 Nonalcoholic steatohepatitis score in Serum or Plasma Nonalcoholic steatohepatitis score Score Pt Ser/Plas Qn NASH score SerPl
2019-10-30 93696-3 Liver steatosis grade in Serum or Plasma Qualitative Liver steatosis grade Find Pt Ser/Plas Ord Liver steatosis grade SerPl Ql
2019-10-30 93693-0 Nonalcoholic steatohepatitis grade in Serum or Plasma Qualitative Nonalcoholic steatohepatitis grade Find Pt Ser/Plas Ord NASH grade SerPl Ql
2019-10-30 93694-8 Nonalcoholic steatohepatitis interpretation in Serum or Plasma Qualitative Nonalcoholic steatohepatitis interpretation Imp Pt Ser/Plas Ord NASH interpretation SerPl-Imp
2019-10-30 93695-5 Liver steatosis score in Serum or Plasma Liver steatosis score Score Pt Ser/Plas Qn Liver steatosis score SerPl
2019-10-30 93697-1 Liver steatosis interpretation in Serum or Plasma Qualitative Liver steatosis interpretation Imp Pt Ser/Plas Ord Liver steatosis interp SerPl-Imp
2019-10-30 93698-9 Gram negative bacterial resistance panel by Molecular genetics method Gram negative bacterial resistance panel - Pt Isolate/Specimen - Molgen GN resist Pnl Islt/Spm
2019-10-30 93699-7 Beta-lactam resistance AmpC blaCMY-2 gene [Presence] by Molecular method Bacterial beta-lactam resistance AmpC blaCMY-2 gene PrThr Pt Isolate/Specimen Ord Molgen AmpC blaCMY-2 gene Islt/Spm Ql
2019-10-30 93700-3 Beta-lactam resistance AmpC blaDHA gene [Presence] by Molecular method Bacterial beta-lactam resistance AmpC blaDHA gene PrThr Pt Isolate/Specimen Ord Molgen AmpC blaDHA gene Islt/Spm Ql
2019-10-30 93701-1 Colistin resistance mcr-2 gene [Presence] by Molecular method Bacterial colistin resistance mcr-2 gene PrThr Pt Isolate/Specimen Ord Molgen Colistin res mcr-2 Islt/Spm Ql
2019-10-30 93702-9 Platelet aggregation ristocetin induced in Platelet rich plasma --15 ug/mL Platelet aggregation.ristocetin induced^15 ug/mL RelACnc Pt PRP Qn PA Rist 15 ug/mL PRP
2019-10-30 93703-7 Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Fibroblast Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel - Pt Fibroblasts - PPT1 + TPP1 Pnl Fib
2019-10-30 93706-0 Ethyl sulfate+Ethyl glucuronide [Mass/volume] in Urine by Screen method Ethyl sulfate+Ethyl glucuronide MCnc Pt Urine Qn Screen ETG EtS Ur Scn-mCnc
2019-10-30 93704-5 Palmitoyl protein thioesterase 1 and Tripeptidyl peptidase 1 panel - Leukocytes Palmitoyl protein thioesterase 1 & Tripeptidyl peptidase 1 panel - Pt WBC - PPT1 + TPP1 Pnl WBC
2019-10-30 93705-2 Ethyl sulfate and Ethyl glucuronide panel - Urine Ethyl sulfate & Ethyl glucuronide panel - Pt Urine - ETG + EtS Pnl Ur
2019-10-30 93708-6 Heptacarboxylporphyrin I/Creatinine [Molar ratio] in Urine Heptacarboxylporphyrin I/Creatinine SRto Pt Urine Qn Hepta-CP I/Creat Ur-sRto
2019-10-30 93709-4 Hexacarboxylporphyrin I/Creatinine [Molar ratio] in Urine Hexacarboxylporphyrin I/Creatinine SRto Pt Urine Qn Hexa-CP I/Creat Ur-sRto
2019-10-30 93707-8 Porphyrin fractions panel - Urine Porphyrin fractions panel - Pt Urine - Porphyrin Fract Pnl Ur
2019-10-30 93710-2 Pentacarboxylporphyrin I/Creatinine [Molar ratio] in Urine Pentacarboxylporphyrin I/Creatinine SRto Pt Urine Qn Penta-CPI/Creat Ur-sRto
2019-10-30 93713-6 Epstein Barr virus capsid IgG Ab [Presence] in Serum from Donor by Immunoassay Epstein Barr virus capsid Ab.IgG PrThr Pt Ser^Donor Ord IA EBV VCA IgG Ser Donr Ql IA
2019-10-30 93712-8 Epstein Barr virus nuclear Ab [Presence] in Serum from Donor by Immunoassay Epstein Barr virus nuclear Ab PrThr Pt Ser^Donor Ord IA EBV NA Ab Ser Donr Ql IA
2019-10-30 93711-0 Epstein Barr virus Ab panel - Serum from Donor Epstein Barr virus Ab panel - Pt Ser^Donor - EBV Ab Pnl Ser Donr
2019-10-30 93714-4 Epstein Barr virus capsid IgM Ab [Presence] in Serum from Donor by Immunoassay Epstein Barr virus capsid Ab.IgM PrThr Pt Ser^Donor Ord IA EBV VCA IgM Ser Donr Ql IA
2019-10-30 93716-9 Francisella tularensis IgM Ab [Presence] in Serum by Immunoassay Francisella tularensis Ab.IgM PrThr Pt Ser Ord IA F tular IgM Ser Ql IA
2019-10-30 93715-1 Francisella tularensis IgG and IgM panel - Serum Francisella tularensis Ab.IgG & IgM panel - Pt Ser - F. tularensis IgG+ IgM Pnl Ser
2019-10-30 93717-7 Francisella tularensis IgG Ab [Presence] in Serum by Immunoassay Francisella tularensis Ab.IgG PrThr Pt Ser Ord IA F tular IgG Ser Ql IA
2019-10-30 93718-5 Francisella tularensis IgG and IgM [Interpretation] in Serum Francisella tularensis Ab.IgG & IgM Imp Pt Ser Nom F tular IgG+IgM Ser-Imp
2019-10-29 93684-9 Ammonia [Moles/volume] in Arterial blood Ammonia SCnc Pt BldA Qn Ammonia BldA-sCnc
2019-10-29 93685-6 Gas and Carbon monoxide and Electrolytes panel - Arterial blood Gas & CO & electrolytes panel - Pt BldA Qn Gas + CO + Electrolytes Pnl BldA
2019-10-29 93686-4 Psychosine [Moles/volume] in Cerebral spinal fluid Psychosine SCnc Pt CSF Qn Psychosine CSF-sCnc
2019-10-29 93687-2 Psychosine [Moles/mass] in Red Blood Cells Psychosine SCnt Pt RBC Qn Psychosine RBC-sCnt
2019-10-29 93688-0 Psychosine [Moles/volume] in DBS Psychosine SCnc Pt Bld.dot Qn Psychosine DBS-sCnc
2019-10-29 93689-8 Thrombospondin type-1 domain-containing 7A IgG Ab [Titer] in Serum or Plasma by Cell binding assay immunofluorescent assay Thrombospondin type-1 domain-containing 7A Ab.IgG Titr Pt Ser/Plas Qn CBA IFA THSD7A IgG Titr SerPl CBA IFA
2019-10-29 93690-6 BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal BRAF gene.p.Val600 mutations Prid Pt Plas.cfDNA Nom Molgen BRAF p.V600 mutations Plas.cfDNA
2019-10-18 93667-4 WellRx Questionnaire - revised WellRx Questionnaire - revised - Pt ^Patient - WellRx
2019-10-18 93668-2 Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2 months [WellRx] Did you or others you live with eat smaller meals or skip meals because you didn't have money for food in the past 2M Find 2M ^Patient Ord WellRx
2019-10-18 93669-0 Are you homeless or worried that you might be in the future [WellRx] Are you homeless or worried that you might be in the future Find Pt ^Patient Ord WellRx
2019-10-18 93670-8 Do you have trouble paying for your gas or electricity bills [WellRx] Do you have trouble paying for your gas or electricity bills Find Pt ^Patient Ord WellRx
2019-10-18 93671-6 Do you have trouble finding or paying for transportation [WellRx] Do you have trouble finding or paying for transportation Find Pt ^Patient Ord WellRx
2019-10-18 93672-4 Do you need daycare, or better daycare, for your kids [WellRx] Do you need daycare, or better daycare, for your kids Find Pt ^Patient Ord WellRx
2019-10-18 93673-2 Are you unemployed or without regular income [WellRx] Are you unemployed or without regular income Find Pt ^Patient Ord WellRx
2019-10-18 93674-0 Do you need help finding a better job [WellRx] Do you need help finding a better job Find Pt ^Patient Ord WellRx
2019-10-18 93675-7 Do you need help getting more education [WellRx] Do you need help getting more education Find Pt ^Patient Ord WellRx
2019-10-18 93676-5 Are you concerned about someone in your home using drugs or alcohol [WellRx] Are you concerned about someone in your home using drugs or alcohol Find Pt ^Patient Ord WellRx
2019-10-18 93677-3 Do you need help with legal issues [WellRx] Do you need help with legal issues Find Pt ^Patient Ord WellRx
2019-10-18 93678-1 Have you been at the emergency department more than twice in the last 6 months [WellRx] Have you been at the emergency department more than twice in the last 6Mo Find 6Mo ^Patient Ord WellRx
2019-10-18 93679-9 Number of visits to the emergency department in last 6 months Number of visits to the emergency department in last 6Mo Num 6M ^Patient Qn
2019-10-18 93680-7 Hospitalized in the last 6 months Hospitalized in the last 6Mo Find 6Mo ^Patient Ord
2019-10-18 93681-5 Number of times hospitalized in last 6 months Number of times hospitalized in last 6Mo Num 6Mo ^Patient Qn
2019-10-18 93683-1 Is anyone in your home threatening or abusing you [WellRx] Is anyone in your home threatening or abusing you Find Pt ^Patient Ord WellRx
2019-10-18 93682-3 Do you feel unsafe in your daily life [WellRx] Do you feel unsafe in your daily life Find Pt ^Patient Ord WellRx
2019-10-17 93666-6 Home accessibility modification panel Home accessibility modification panel - Pt ^Patient - Home accessibility mod panel
2019-10-15 93664-1 Pericardial effusion by US Pericardial effusion Find Pt Pericardial space Ord US Pericardial effusion US
2019-10-15 93665-8 Pulmonary valve Regurgitant blood flow pressure half-time by US.doppler Regurgitant blood flow pressure half-time Time Pt Pulmonary valve Qn US.doppler Pulm valve Regurg PHT DOP
2019-10-11 93608-8 Left ventricular Maximum atrial contraction strain rate by US 3D Atrial contraction strain rate.max ARat Pt Heart.ventricle.left Qn US.3D LV Max atrial contract strain rate 3D US
2019-10-11 93609-6 Left ventricular Maximum circumferential atrial contraction strain rate by US 3D Atrial contraction strain rate.circumferential.max LenRto Pt Heart.ventricle.left Qn US.3D LV Max circ atrial contract st rt 3D US
2019-10-11 93610-4 Left ventricular Maximum longitudinal atrial contraction strain rate by US 3D Atrial contraction strain rate.longitudinal.max ARat Pt Heart.ventricle.left Qn US.3D LV Max long atrial contract str rt 3D US
2019-10-11 93611-2 Left ventricular Maximum circumferential strain rate during early diastole by US 3D Circumferential strain rate.early diastole.max ARat Pt Heart.ventricle.left Qn US.3D LV Max circ strain rate early dia 3D US
2019-10-11 93612-0 Left ventricular Maximum longitudinal strain rate during early diastole by US 3D Longitudinal strain rate.early diastole.max ARat Pt Heart.ventricle.left Qn US.3D LV Max long strain rate early dias 3D US
2019-10-11 93613-8 Left ventricular Maximum circumferential strain rate during systole by US 3D Circumferential strain rate.systole.max ARat Pt Heart.ventricle.left Qn US.3D LV Max circ strain rate sys 3D US
2019-10-11 93614-6 Left ventricular Maximum longitudinal strain rate during systole by US 3D Longitudinal strain rate.systole.max ARat Pt Heart.ventricle.left Qn US.3D LV Max long strain rate sys 3D US
2019-10-11 93615-3 Left ventricular Maximum area strain by US 3D Area strain.max LenRto Pt Heart.ventricle.left Qn US.3D LV Max area strain 3D US
2019-10-11 93616-1 Left ventricular Maximum circumferential strain by US 3D Circumferential strain.max LenRto Pt Heart.ventricle.left Qn US.3D LV Max circ strain 3D US
2019-10-11 93617-9 Left ventricular Maximum longitudinal strain by US 3D Longitudinal strain.max LenRto Pt Heart.ventricle.left Qn US.3D LV Max long strain 3D US
2019-10-11 93618-7 Tricuspid valve Regurgitant volume by US.doppler+Calculated by PISA method Regurgitant volume Vol Pt Tricuspid valve Qn US.doppler+Calculated by PISA method TV Reg vol PISA
2019-10-11 93620-3 Tricuspid valve Regurgitant blood velocity-time integral by US.doppler Regurgitant blood velocity-time integral Len Pt Tricuspid valve Qn US.doppler TV Regurg bld vel VTI DOP
2019-10-11 93619-5 Hepatic vein Systolic flow reversal by US.doppler Blood flow reversal.systolic Find Pt Hepatic vein Ord US.doppler Hep v Sys flow reversal DOP
2019-10-11 93623-7 Main pulmonary artery Diastolic flow reversal by US.doppler Blood flow reversal.diastolic Find Pt Pulmonary artery.main Ord US.doppler MPA Dia flow reversal DOP
2019-10-11 93622-9 Right ventricular Systolic time by US.doppler Systolic time Time Pt Heart.ventricle.right Qn US.doppler RV Sys time DOP
2019-10-11 93621-1 Tricuspid valve Regurgitant orifice area by US.doppler.color Regurgitant orifice area Area Pt Tricuspid valve Qn US.doppler.color TV ROA DOP.color
2019-10-11 93624-5 Pulmonic valve Pressure gradient.early diastole.max by US.doppler Pressure gradient.early diastole.max PressDiff Pt Pulmonic valve Qn US.doppler PV Pres grad.early dias.max DOP
2019-10-11 93625-2 Pulmonary valve Regurgitant blood flow velocity.early diastole by Ultrasound.doppler.PW Regurgitant blood flow velocity.early diastole Vel Pt Pulmonary valve Qn US.doppler.PW Pulm valve Regurg vel.early dia DOP.PW
2019-10-11 93626-0 Pulmonary vein Blood flow velocity.S2 wave by Ultrasound.doppler.PW Blood flow velocity.S2 wave Vel Pt Pulmonary vein Qn US.doppler.PW Pulm v Bld vel.S2 wave DOP.PW
2019-10-11 93627-8 Pulmonary vein Blood flow velocity.S1 wave by Ultrasound.doppler.PW Blood flow velocity.S1 wave Vel Pt Pulmonary vein Qn US.doppler.PW Pulm v Blood flow vel.S1 wave DOP.PW
2019-10-11 93628-6 Mitral valve Regurgitant blood velocity-time integral by US.doppler Regurgitant blood velocity-time integral Len Pt Mitral valve Qn US.doppler MV Regurg bld vel VTI DOP
2019-10-11 93629-4 Aorta abdominal Holodiastolic flow reversal by US.doppler Blood flow reversal.holodiastolic Find Pt Aorta.abdominal Ord US.doppler Ab Ao Holodias flow reversal DOP
2019-10-11 93630-2 Aortic valve Regurgitant fraction by US.doppler+Calculated by PISA method Regurgitant fraction VFr Pt Aortic valve Qn US.doppler+Calculated by PISA method AV Regurg fraction PISA
2019-10-11 93631-0 Aortic valve Regurgitant blood velocity-time integral by US.doppler Regurgitant blood velocity-time integral Len Pt Aortic valve Qn US.doppler AV Regurg bld vel VTI DOP
2019-10-11 93632-8 Heart Left ventricular outflow tract/Aortic valve VTI by US.doppler Velocity-time integral.left ventricular outflow tract/velocity-time integral.aortic valve LenRto Pt Heart Qn US.doppler Hrt LVOT/AV VTI DOP
2019-10-11 93633-6 Heart Left ventricular outflow tract/Maximum blood flow aortic valve by US.doppler Blood flow velocity.max.left ventricular outflow tract/blood flow.max.aortic valve VelRto Pt Heart Qn US.doppler Hrt LVOT/Aortic valve DOP
2019-10-11 93634-4 Inferior vena cava Collapse by US Collapse Find Pt Vena cava.inferior Ord US IVC Collapse US
2019-10-11 93636-9 Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A2C+Calc by single plane area-length method End-systolic volume/Body surface area ArVol Pt Heart.atrium.left Qn US.2D.A2C+Calc by single plane area-length method LA ES vol/BSA A2C SP A-L
2019-10-11 93637-7 Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A4C+Calc by single plane area-length method End-systolic volume/Body surface area ArVol Pt Heart.atrium.left Qn US.2D.A4C+Calc by single plane area-length method LA ES vol/BSA A4C SP A-L
2019-10-11 93635-1 Right atrial End-systolic volume by US.2D.A4C End-systolic volume Vol Pt Heart.atrium.right Qn US.2D.A4C RA ES vol A4C
2019-10-11 93639-3 Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A4C+Calculated by single plane method of disks End-systolic volume/Body surface area ArVol Pt Heart.atrium.left Qn US.2D.A4C+Calc by single plane method of disks LA ES vol/BSA A4C MOD
2019-10-11 93640-1 Left atrial End-systolic volume by US.2D.A2C+Calc by single plane area-length method End-systolic volume Vol Pt Heart.atrium.left Qn US.2D.A2C+Calc by single plane area-length method LA ES vol A2C SP A-L
2019-10-11 93638-5 Left atrial End-systolic volume/Body surface area [Volume/Area] by US.2D.A2C+Calculated by single plane method of disks End-systolic volume/Body surface area ArVol Pt Heart.atrium.left Qn US.2D.A2C+Calc by single plane method of disks LA ES vol/BSA A2C MOD
2019-10-11 93641-9 Left atrial End-systolic volume by US.2D.A4C+Calc by single plane area-length method End-systolic volume Vol Pt Heart.atrium.left Qn US.2D.A4C+Calc by single plane area-length method LA ES vol A4C SP A-L
2019-10-11 93642-7 Right ventricular outflow tract proximal Diameter by US.2D.PSAX Diameter Len Pt Heart.ventricle.right.outflow tract.proximal Qn US.2D.PSAX Proximal RVOT Diam PSAX
2019-10-11 93643-5 Right ventricular Major axis diastole [Length] by US.2D.A4C Major axis.diastole Len Pt Heart.ventricle.right Qn US.2D.A4C RV Major axis dias A4C
2019-10-11 93644-3 Left ventricular Ejection fraction by US.2D.A2C+Calc by single plane area-length method Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane area-length method LV EF A2C SP A-L
2019-10-11 93645-0 Left ventricular Ejection fraction by US.2D.A4C+Calc by single plane area-length method Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane area-length method LV EF A4C SP A-L
2019-10-11 93646-8 Left ventricular Ejection fraction by US.2D+Calculated by biplane area-length method Ejection fraction VFr Pt Heart.ventricle.left Qn US.2D+Calculated by biplane area-length method LV EF Biplane area-length
2019-10-11 93647-6 Left ventricular Cardiac output by US.2D.A2C+Calc by single plane area-length method Cardiac output VRat Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane area-length method LV Output A2C SP A-L
2019-10-11 93648-4 Left ventricular Cardiac output by US.2D.A4C+Calc by single plane area-length method Cardiac output VRat Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane area-length method LV Output A4C SP A-L
2019-10-11 93651-8 Left ventricular Cardiac output by US.2D.A4C+Calculated by single plane method of disks Cardiac output VRat Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane method of disks LV Output A4C MOD
2019-10-11 93649-2 Left ventricular Cardiac output by US.2D+Calculated by biplane area-length method Cardiac output VRat Pt Heart.ventricle.left Qn US.2D+Calculated by biplane area-length method LV Output Biplane area-length
2019-10-11 93650-0 Left ventricular Cardiac output by US.2D.A2C+Calculated by single plane method of disks Cardiac output VRat Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane method of disks LV Output A2C MOD
2019-10-11 93652-6 Left ventricular Stroke volume by US.2D.A2C+Calc by single plane area-length method Stroke volume Vol Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane area-length method LV SV A2C SP A-L
2019-10-11 93653-4 Left ventricular Stroke volume by US.2D.A4C+Calc by single plane area-length method Stroke volume Vol Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane area-length method LV SV A4C SP A-L
2019-10-11 93654-2 Left ventricular Stroke volume by US.2D+Calculated by biplane area-length method Stroke volume Vol Pt Heart.ventricle.left Qn US.2D+Calculated by biplane area-length method LV SV Biplane area-length
2019-10-11 93655-9 Left ventricular Stroke volume by US.2D.A2C+Calculated by single plane method of disks Stroke volume Vol Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane method of disks LV SV A2C MOD
2019-10-11 93656-7 Left ventricular Stroke volume by US.2D.A4C+Calculated by single plane method of disks Stroke volume Vol Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane method of disks LV SV A4C MOD
2019-10-11 93657-5 Left ventricular End-systolic volume by US.2D.A2C+Calc by single plane area-length method End-systolic volume Vol Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane area-length method LV ES vol A2C SP A-L
2019-10-11 93658-3 Left ventricular End-systolic volume by US.2D.A4C+Calc by single plane area-length method End-systolic volume Vol Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane area-length method LV ES vol A4C SP A-L
2019-10-11 93659-1 Left ventricular End-systolic volume by US.2D+Calculated by biplane area-length method End-systolic volume Vol Pt Heart.ventricle.left Qn US.2D+Calculated by biplane area-length method LV ES vol Biplane area-length
2019-10-11 93660-9 Left ventricular End-diastolic volume by US.2D.A2C+Calc by single plane area-length method End-diastolic volume Vol Pt Heart.ventricle.left Qn US.2D.A2C+Calc by single plane area-length method LV ED vol A2C SP A-L
2019-10-11 93661-7 Left ventricular End-diastolic volume by US.2D.A4C+Calc by single plane area-length method End-diastolic volume Vol Pt Heart.ventricle.left Qn US.2D.A4C+Calc by single plane area-length method LV ED vol A4C SP A-L
2019-10-11 93662-5 Left ventricular End-diastolic volume by US.2D+Calculated by biplane area-length method End-diastolic volume Vol Pt Heart.ventricle.left Qn US.2D+Calculated by biplane area-length method LV ED vol Biplane area-length
2019-10-11 93663-3 Left ventricular Sphericity index.end diastole by US Sphericity index.end diastole LenRto Pt Heart.ventricle.left Qn US LV ED sphericity index US
2019-10-08 93598-1 Intensity of ideation [C-SSRS.PCI] Intensity of ideation - Pt ^Patient - C-SSRS.PCI
2019-10-08 93599-9 Frequency of most severe suicidal ideation 1 month [C-SSRS.PCI] Frequency of most severe suicidal ideation Find 1Mo ^Patient Ord C-SSRS.PCI
2019-10-08 93600-5 Frequency of most severe suicidal ideation Lifetime [C-SSRS.PCI] Frequency of most severe suicidal ideation Find Lifetime ^Patient Ord C-SSRS.PCI
2019-10-08 93603-9 CT Head and Cervical spine WO and W contrast IV Multisection^WO & W contrast IV Find Pt Head & Neck>Spine.cervical Doc CT CT Head+C-spine WO+W contr IV
2019-10-08 93604-7 US.doppler Lower extremity arteries+veins - bilateral Multisection Find Pt Lower extremity.bilateral>Lower extremity arteries+Lower extremity veins Doc US.doppler DOP LE aa+vv-Bl
2019-10-08 93605-4 XR Skull to Coccyx 2 or 3 Views Views 2 or 3 Find Pt Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccy Doc XR XR Skull to Coccyx 2V or 3V
2019-10-08 93607-0 XR Skull to Coccyx GE 6 Views Views GE 6 Find Pt Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccy Doc XR XR Skull to Coccyx GE 6V
2019-10-08 93606-2 XR Skull to Coccyx 4 or 5 Views Views 4 or 5 Find Pt Head>Skull & Neck>Spine.cervical & Chest>Spine.thoracic & Abdomen>Spine.lumbar & Pelvis>Sacrum+Coccy Doc XR XR Skull to Coccyx 4V or 5V
2019-10-01 93504-9 Cholesterol crystals [Presence] in Stone by X-ray diffraction Cholesterol crystals PrThr Pt Calculus Ord XR diffraction Cholest Cry Stone Ql XR diff
2019-10-01 93505-6 Heptacarboxylporphyrin I [Moles/time] in 24 hour Urine Heptacarboxylporphyrin I SRat 24H Urine Qn Hepta-CP I 24h Ur-sRate
2019-10-01 93506-4 Heptacarboxylporphyrin III [Moles/time] in 24 hour Urine Heptacarboxylporphyrin III SRat 24H Urine Qn Hepta-CP3 24h Ur-sRate
2019-10-01 93509-8 Pentacarboxylporphyrin I [Moles/time] in 24 hour Urine Pentacarboxylporphyrin I SRat 24H Urine Qn Penta-CPI 24h Ur-sRate
2019-10-01 93507-2 Hexacarboxylporphyrin I [Moles/time] in 24 hour Urine Hexacarboxylporphyrin I SRat 24H Urine Qn Hexa-CP I 24h Ur-sRate
2019-10-01 93508-0 Hexacarboxylporphyrin III [Moles/time] in 24 hour Urine Hexacarboxylporphyrin III SRat 24H Urine Qn Hexa-CPr3 24h Ur-sRate
2019-10-01 93510-6 Pentacarboxylporphyrin III [Moles/time] in 24 hour Urine Pentacarboxylporphyrin III SRat 24H Urine Qn Penta-CP3 24h Ur-sRate
2019-10-01 93511-4 Rickettsia rickettsii and Coxiella burnetii phase 1 and Coxiella burnetii phase 2 IgG panel - Serum Rickettsia rickettsii & Coxiella burnetii phase 1 & Coxiella burnetii phase 2 Ab.IgG panel - Pt Ser - R. rickettsii + C. burnetii 1 2 IgG Pnl
2019-09-20 93485-1 Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent [C-SSRS] Columbia - suicide severity rating scale - very young child or cognitively impaired - lifetime recent - Pt ^Patient - C-SSRS
2019-09-20 93486-9 Has subject engaged in self-injurious behavior, intent unknown 3 months Has subject engaged in self-injurious behavior, intent unknown Find 3Mo ^Patient Ord
2019-09-20 93487-7 Has subject engaged in self-injurious behavior, intent unknown Lifetime Has subject engaged in self-injurious behavior, intent unknown Find Lifetime ^Patient Ord
2019-09-20 93488-5 Guanidinoacetate [Moles/volume] in DBS Guanidinoacetate SCnc Pt Bld.dot Qn Guanidinoacetate DBS-sCnc
2019-09-20 93489-3 AMPAR2 IgG Ab [Presence] in Serum or Plasma by Cell binding assay immunofluorescent assay Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG PrThr Pt Ser/Plas Ord CBA IFA AMPAR2 IgG SerPl Ql CBA IFA
2019-09-20 93490-1 AMPAR2 IgG Ab [Titer] in Serum or Plasma by Immunofluorescence Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG Titr Pt Ser/Plas Qn IF AMPAR2 IgG Titr SerPl IF
2019-09-20 93491-9 AMPAR2 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG PrThr Pt CSF Ord CBA IFA AMPAR2 IgG CSF Ql CBA IFA
2019-09-20 93492-7 AMPAR2 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence Alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor 2 Ab.IgG Titr Pt CSF Qn IF AMPAR2 IgG Titr CSF IF
2019-09-20 93493-5 3-Hydroxy-3-Methylglutaryl-coenzyme A reductase IgG Ab [Units/volume] in Serum by Immunoassay 3-Hydroxy-3-Methylglutaryl-Coenzyme A Reductase Ab.IgG ACnc Pt Ser Qn IA HMGCR IgG Ser IA-aCnc
2019-09-20 93496-8 Nortriptyline [Presence] in Urine by Screen method Nortriptyline PrThr Pt Urine Ord Screen Nortrip Ur Ql Scn
2019-09-20 93494-3 Buprenorphine [Presence] in Urine by Screen method Buprenorphine PrThr Pt Urine Ord Screen Buprenorphine Ur Ql Scn
2019-09-20 93495-0 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine (EDDP) [Presence] in Urine by Screen method 2-Ethylidene-1,5-Dimethyl-3,3-Diphenylpyrrolidine PrThr Pt Urine Ord Screen EDDP Ur Ql Scn
2019-09-20 93497-6 Moxifloxacin 3 ug/mL [Susceptibility] by Method for Slow-growing mycobacteria Moxifloxacin 3.0 ug/mL Susc Pt Isolate OrdQn Method for Slow-growing mycobacteria Moxifloxacin 3 ug/mL Islt SlowMyco
2019-09-20 93498-4 Metabotropic glutamate receptor 1 IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay Metabotropic glutamate receptor 1 Ab.IgG PrThr Pt Ser Ord CBA IFA mGluR1 IgG Ser Ql CBA IFA
2019-09-20 93499-2 Metabotropic glutamate receptor 1 IgG Ab [Titer] in Serum by Immunofluorescence Metabotropic glutamate receptor 1 Ab.IgG Titr Pt Ser Qn IF mGluR1 IgG Titr Ser IF
2019-09-20 93501-5 Metabotropic glutamate receptor 1 IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence Metabotropic glutamate receptor 1 Ab.IgG Titr Pt CSF Qn IF mGluR1 IgG Titr CSF IF
2019-09-20 93502-3 NMDAR subunit 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay N-methyl-D-aspartate receptor subunit 1 Ab.IgG PrThr Pt CSF Ord CBA IFA NMDAR1 IgG CSF Ql CBA IFA
2019-09-20 93500-7 Metabotropic glutamate receptor 1 IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay Metabotropic glutamate receptor 1 Ab.IgG PrThr Pt CSF Ord CBA IFA mGluR1 IgG CSF Ql CBA IFA
2019-09-20 93503-1 NMDAR subunit 1 IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay N-methyl-D-aspartate receptor subunit 1 Ab.IgG PrThr Pt Ser Ord CBA IFA NMDAR1 IgG Ser Ql CBA IFA
2019-09-19 93481-0 Cortisol [Mass/volume] in Serum or Plasma --10 minutes post 1 ug/kg CRH IV Cortisol^10M post 1 ug/kg CRH IV MCnc Pt Ser/Plas Qn Cortis 10M p 1 ug/kg CRH IV SerPl-mCnc
2019-09-19 93480-2 Cortisol post CRH stimulation panel - Serum or Plasma Cortisol post corticotropin releasing hormone stimulation panel - Pt Ser/Plas Qn Cortisol p CRH stimulation Pnl SerPl
2019-09-19 93482-8 Cortisol [Mass/volume] in Serum or Plasma --1 minute pre 1 ug/kg CRH IV Cortisol^1M pre 1 ug/kg CRH IV MCnc Pt Ser/Plas Qn Cortis 1M pre 1 ug/kg CRH IV SerPl-mCnc
2019-09-19 93483-6 Cortisol [Mass/volume] in Serum or Plasma --2 minutes post 1 ug/kg CRH IV Cortisol^2M post 1 ug/kg CRH IV MCnc Pt Ser/Plas Qn Cortis 2M p 1 ug/kg CRH IV SerPl-mCnc
2019-09-19 93484-4 Cortisol [Mass/volume] in Serum or Plasma --5 minutes pre 1 ug/kg CRH IV Cortisol^5M pre 1 ug/kg CRH IV MCnc Pt Ser/Plas Qn Cortis 5M pre 1 ug/kg CRH IV SerPl-mCnc
2019-09-18 93479-4 Observation interpretation Observation interpretation Imp Pt XXX Nom Observation Imp
2019-09-17 93450-5 Coagulation factor VIII inhibitor [Units/volume] in Platelet poor plasma by Chromogenic method Coagulation factor VIII Inhibitor ACnc Pt PPP Qn Chromo Fact VIII Inhib PPP Chro-aCnc
2019-09-17 93451-3 Nor-W-18+Nor-W-15 [Mass/volume] in Urine by Confirmatory method Nor-W-18+Nor-W-15 MCnc Pt Urine Qn Confirm Nor-W-18+Nor-W-15 Ur Cfm-mCnc
2019-09-17 93452-1 W-19 [Mass/volume] in Urine by Confirmatory method W-19 MCnc Pt Urine Qn Confirm W-19 Ur Cfm-mCnc
2019-09-17 93453-9 W-15 [Mass/volume] in Urine by Confirmatory method W-15 MCnc Pt Urine Qn Confirm W-15 Ur Cfm-mCnc
2019-09-17 93454-7 W-18 [Mass/volume] in Urine by Confirmatory method W-18 MCnc Pt Urine Qn Confirm W-18 Ur Cfm-mCnc
2019-09-17 93455-4 IC-26 [Mass/volume] in Urine by Confirmatory method IC-26 MCnc Pt Urine Qn Confirm IC-26 Ur Cfm-mCnc
2019-09-17 93456-2 MT-45 [Mass/volume] in Urine by Confirmatory method MT-45 MCnc Pt Urine Qn Confirm MT-45 Ur Cfm-mCnc
2019-09-17 93458-8 AH-8533 [Mass/volume] in Urine by Confirmatory method AH-8533 MCnc Pt Urine Qn Confirm AH-8533 Ur Cfm-mCnc
2019-09-17 93459-6 U-47700 [Mass/volume] in Urine by Confirmatory method U-47700 MCnc Pt Urine Qn Confirm U-47700 Ur Cfm-mCnc
2019-09-17 93457-0 AH-8529 [Mass/volume] in Urine by Confirmatory method AH-8529 MCnc Pt Urine Qn Confirm AH-8529 Ur Cfm-mCnc
2019-09-17 93460-4 AH-7921 [Mass/volume] in Urine by Confirmatory method AH-7921 MCnc Pt Urine Qn Confirm AH-7921 Ur Cfm-mCnc
2019-09-17 93461-2 4-Methoxybutyrylfentanyl [Mass/volume] in Urine by Confirmatory method 4-Methoxybutyrylfentanyl MCnc Pt Urine Qn Confirm 4-Methbutfentanyl Ur Cfm-mCnc
2019-09-17 93462-0 Norcarfentanil [Mass/volume] in Urine by Confirmatory method Norcarfentanil MCnc Pt Urine Qn Confirm Norcarfentanil Ur Cfm-mCnc
2019-09-17 93463-8 Ocfentanil [Mass/volume] in Urine by Confirmatory method Ocfentanil MCnc Pt Urine Qn Confirm Ocfentanil Ur Cfm-mCnc
2019-09-17 93464-6 p-Fluorofentanyl [Mass/volume] in Urine by Confirmatory method 4-Fluorofentanyl MCnc Pt Urine Qn Confirm 4-Fluorofentanyl Ur Cfm-mCnc
2019-09-17 93465-3 3-Methylfentanyl [Mass/volume] in Urine by Confirmatory method 3-Methylfentanyl MCnc Pt Urine Qn Confirm 3-Me-fentanyl Ur Cfm-mCnc
2019-09-17 93466-1 Valerylfentanyl [Mass/volume] in Urine by Confirmatory method Valerylfentanyl MCnc Pt Urine Qn Confirm Valerylfentanyl Ur Cfm-mCnc
2019-09-17 93467-9 Butyrylfentanyl [Mass/volume] in Urine by Confirmatory method Butyrylfentanyl MCnc Pt Urine Qn Confirm Butyrylfentanyl Ur Cfm-mCnc
2019-09-17 93468-7 Acrylfentanyl [Mass/volume] in Urine by Confirmatory method Acrylfentanyl MCnc Pt Urine Qn Confirm Acrylfentanyl Ur Cfm-mCnc
2019-09-17 93471-1 Acetyl norfentanyl [Mass/volume] in Urine by Confirmatory method Acetyl norfentanyl MCnc Pt Urine Qn Confirm Acetyl norfentanyl Ur Cfm-mCnc
2019-09-17 93470-3 Furanylfentanyl [Mass/volume] in Urine by Confirmatory method Furanylfentanyl MCnc Pt Urine Qn Confirm Furanylfentanyl Ur Cfm-mCnc
2019-09-17 93469-5 4-Fluorobutyrylfentanyl [Mass/volume] in Urine by Confirmatory method 4-Fluorobutyrylfentanyl MCnc Pt Urine Qn Confirm 4-Fluorobutyrylfentanyl Ur Cfm-mCnc
2019-09-17 93473-7 Beta hydroxythiofentanyl [Mass/volume] in Urine by Confirmatory method Beta hydroxythiofentanyl MCnc Pt Urine Qn Confirm B-OH thiofentanyl Ur Cfm-mCnc
2019-09-17 93472-9 4-Methylphenethylacetylfentanyl [Mass/volume] in Urine by Confirmatory method 4-Methylphenethylacetylfentanyl MCnc Pt Urine Qn Confirm 4-MetPhenEthAcetFentanyl Ur Cfm-mCnc
2019-09-17 93474-5 Synthetic opioids panel - Urine by Confirmatory method Synthetic opioids panel - Pt Urine - Confirm Synthetic opioids pnl Ur Cfm
2019-09-17 93475-2 Busulfan clearance from plasma over study Busulfan clearance VRatCnt Stdy Plas Qn Busulfan Cl from Plas
2019-09-17 93476-0 Busulfan [Area under the curve] in Plasma Busulfan TmSCnc Stdy Plas Qn Busulfan Plas-AUC
2019-09-17 93477-8 Busulfan given [Mass] in unspecified time Dose Busulfan given Mass XXX Dose Qn Busulfan Gvn ?Tm Dose Qn
2019-09-17 93478-6 Busulfan area under the curve panel - Plasma Busulfan area under the curve panel - Stdy Plas Qn Busulfan AUC Pnl Plas
2019-09-13 93441-4 Home accessibility modification date Home accessibility modification date Date Pt ^Patient Qn Home access mod date
2019-09-13 93442-2 Advance directive document format Advance directive document format Find Pt ^Patient Nom Advance directive document format
2019-09-13 93443-0 Self-care abilities Self-care abilities Find Pt ^Patient Nom Self-care abilities
2019-09-13 93444-8 Accessibility of home entrance Accessibility of home entrance Find Pt ^Patient Nom Access of home entrance
2019-09-13 93445-5 Accessibility note Patient's home Nurse Accessibility note Find Pt Patient's home Doc Nurse Accessibility note Pt's home Nurse
2019-09-13 93446-3 Accessibility of home interior Accessibility of home interior Find Pt ^Patient Nom Access home int
2019-09-13 93447-1 Home accessibility modification responsible party Home accessibility modification responsible party Find Pt ^Patient Nom Home access mod responsible party
2019-09-13 93448-9 Home accessibility evaluation status Home accessibility evaluation status Find Pt ^Patient Nom Home access eval status
2019-09-13 93449-7 Appointment of legal guardian Appointment of legal guardian Find Pt ^Patient Nom Appt legal guardian
2019-09-12 93418-2 (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript [Presence] in Tissue by Molecular genetics method (8;8)(q13;q21)(HEY1,NCOA2) fusion transcript PrThr Pt Tiss Ord Molgen (8;8)(HEY1,NCOA2) Tiss Ql
2019-09-12 93419-0 Alpha 1 antitrypsin fecal clearance panel - Serum or Plasma and Stool Alpha 1 antitrypsin fecal clearance panel - Pt Ser/Plas+Stool Qn A1AT Cl Pnl SerPl+Stl
2019-09-12 93420-8 APOA1 gene full mutation analysis in Blood or Tissue by Sequencing APOA1 gene full mutation analysis Find Pt Bld/Tiss Doc Sequencing APOA1 Full Mut Anl Bld/T Seq
2019-09-12 93421-6 Glial fibrillary acidic protein IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence Glial fibrillary acidic protein Ab.IgG Titr Pt CSF Qn IF GFAP IgG Titr CSF IF
2019-09-12 93422-4 Glial fibrillary acidic protein.alpha IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay Glial fibrillary acidic protein.alpha Ab.IgG PrThr Pt CSF Ord CBA IFA GFAP alpha IgG CSF Ql CBA IFA
2019-09-12 93423-2 Glial fibrillary acidic protein IgG Ab [Titer] in Serum by Immunofluorescence Glial fibrillary acidic protein Ab.IgG Titr Pt Ser Qn IF GFAP IgG Titr Ser IF
2019-09-12 93424-0 Glial fibrillary acidic protein.alpha IgG Ab [Presence] in Serum by Cell binding assay immunofluorescent assay Glial fibrillary acidic protein.alpha Ab.IgG PrThr Pt Ser Ord CBA IFA GFAP alpha IgG Ser Ql CBA IFA
2019-09-12 93425-7 GABABR IgG Ab [Titer] in Cerebral spinal fluid by Immunofluorescence Gamma aminobutyrate B receptor Ab.IgG Titr Pt CSF Qn IF GABABR IgG Titr CSF IF
2019-09-12 93426-5 GABABR IgG Ab [Presence] in Cerebral spinal fluid by Cell binding assay immunofluorescent assay Gamma aminobutyrate B receptor Ab.IgG PrThr Pt CSF Ord CBA IFA GABABR IgG CSF Ql CBA IFA
2019-09-12 93427-3 GABABR IgG Ab [Titer] in Serum or Plasma by Immunofluorescence Gamma aminobutyrate B receptor Ab.IgG Titr Pt Ser/Plas Qn IF GABABR IgG Titr SerPl IF
2019-09-12 93428-1 GABABR IgG Ab [Presence] in Serum or Plasma by Cell binding assay immunofluorescent assay Gamma aminobutyrate B receptor Ab.IgG PrThr Pt Ser/Plas Ord CBA IFA GABABR IgG SerPl Ql CBA IFA
2019-09-12 93429-9 Blastomyces sp Ag [Mass/volume] in Urine by Immunoassay Blastomyces sp Ag MCnc Pt Urine Qn IA Blastomyces Ag Ur IA-mCnc
2019-09-12 93430-7 Blastomyces sp Ag [Mass/volume] in Serum or Plasma by Immunoassay Blastomyces sp Ag MCnc Pt Ser/Plas Qn IA Blastomyces Ag SerPl IA-mCnc
2019-09-12 93432-3 Blastomyces sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay Blastomyces sp Ag MCnc Pt BAL Qn IA Blastomyces Ag BAL IA-mCnc
2019-09-12 93431-5 Blastomyces sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay Blastomyces sp Ag MCnc Pt CSF Qn IA Blastomyces Ag CSF IA-mCnc
2019-09-12 93435-6 Busulfan [Mass/volume] in Plasma --1 hour post busulfan infusion completion Busulfan^1H post busulfan infusion completion MCnc Pt Plas Qn Busulfan 1h p busulfan Plas-mCnc
2019-09-12 93433-1 Busulfan [Mass/volume] in Plasma --4 hours post busulfan infusion completion Busulfan^4H post busulfan infusion completion MCnc Pt Plas Qn Busulfan 4h p busulfan Plas-mCnc
2019-09-12 93434-9 Busulfan [Mass/volume] in Plasma --2 hours post busulfan infusion completion Busulfan^2H post busulfan infusion completion MCnc Pt Plas Qn Busulfan 2h p busulfan Plas-mCnc
2019-09-12 93436-4 Busulfan [Mass/volume] in Plasma --immediately post busulfan infusion completion Busulfan^immediately post busulfan infusion completion MCnc Pt Plas Qn Busulfan immed p busulfan Plas-mCnc
2019-09-12 93437-2 Lurasidone [Mass/volume] in Serum or Plasma Lurasidone MCnc Pt Ser/Plas Qn Lurasidone SerPl-mCnc
2019-09-12 93438-0 Herpes simplex virus 2 DNA [Presence] in Blood by NAA with non-probe detection Herpes Simplex Virus 2 DNA PrThr Pt Bld Ord Non-probe.amp.tar HSV2 DNA Bld Ql NAA+non-probe
2019-09-12 93439-8 Herpes simplex virus 1 DNA [Presence] in Blood by NAA with non-probe detection Herpes Simplex Virus 1 DNA PrThr Pt Bld Ord Non-probe.amp.tar HSV1 DNA Bld Ql NAA+non-probe
2019-09-12 93440-6 Herpes simplex virus 1 and 2 DNA panel - Blood by NAA with non-probe detection Herpes Simplex Virus 1 & 2 DNA Panel - Pt Bld - Non-probe.amp.tar HSV 1+2 DNA Pnl Bld NAA+non-probe
2019-09-11 93415-8 Disorganized thinking in last 3 days [CMS Assessment] Disorganized thinking in last 3D Find 3D ^Patient Ord CMS Assessment
2019-09-11 93416-6 Inattention in last 3 days [CMS Assessment] Inattention in last 3D Find 3D ^Patient Nom CMS Assessment
2019-09-11 93417-4 IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) [CMS Assessment] IRF-PAI v4.0, LCDS v5.00 - Signs and Symptoms of Delirium (from CAM) - 3D ^Patient - CMS Assessment
2019-09-10 93411-7 COMT gene product metabolic activity interpretation in Blood or Tissue by Molecular genetics method COMT gene product metabolic activity interpretation Imp Pt Bld/Tiss Nom Molgen COMT gene prod met activ Bld/T-Imp
2019-09-10 93412-5 SLCO1B1 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method SLCO1B1 gene targeted mutation analysis Find Pt Bld/Tiss Doc Molgen SLCO1B1 Mut Anl Bld/T
2019-09-10 93413-3 Mechanical circulatory support Consultation note Mechanical circulatory support+consultation note Find Pt {Setting} Doc {Role} MCS+consult note
2019-09-09 93384-6 Serratia sp DNA [Presence] by NAA with probe detection in Positive blood culture Serratia sp DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar Serratia sp DNA Bld Pos Ql NAA+probe
2019-09-09 93385-3 Salmonella sp DNA [Presence] by NAA with probe detection in Positive blood culture Salmonella sp DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar Salmonella DNA Bld Pos Ql NAA+probe
2019-09-09 93386-1 Pseudomonas aeruginosa DNA [Presence] by NAA with probe detection in Positive blood culture Pseudomonas aeruginosa DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar P aeruginosa DNA Bld Pos Ql NAA+probe
2019-09-09 93387-9 Proteus mirabilis DNA [Presence] by NAA with probe detection in Positive blood culture Proteus mirabilis DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar P mirabilis DNA Bld Pos Ql NAA+probe
2019-09-09 93388-7 Neisseria meningitidis DNA [Presence] by NAA with probe detection in Positive blood culture Neisseria meningitidis DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar N men DNA Bld Pos Ql NAA+probe
2019-09-09 93389-5 Gram positive bacteria DNA [Presence] by NAA with probe detection in Positive blood culture Gram positive bacteria DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar GP bact DNA Bld Pos Ql NAA+probe
2019-09-09 93390-3 Carbapenem resistance blaOXA-23-like+blaOXA-48-like genes [Presence] in Isolate or Specimen by Molecular genetics method Bacterial carbapenem resistance blaOXA-23-like+blaOXA-48-like genes PrThr Pt Isolate/Specimen Ord Molgen blaOXA-23+48-like genes Islt/Spm Ql
2019-09-09 93391-1 Stenotrophomonas maltophilia DNA [Presence] by NAA with probe detection in Positive blood culture Stenotrophomonas maltophilia DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar S maltophilia DNA Bld Pos Ql NAA+probe
2019-09-09 93393-7 Proteus sp DNA [Presence] by NAA with probe detection in Positive blood culture Proteus sp DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar Proteus sp DNA Bld Pos Ql NAA+probe
2019-09-09 93394-5 Morganella morganii DNA [Presence] by NAA with probe detection in Positive blood culture Morganella morganii DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar M. morganii DNA Bld Pos Ql NAA+probe
2019-09-09 93392-9 Serratia marcescens DNA [Presence] by NAA with probe detection in Positive blood culture Serratia marcescens DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar S marcescens DNA Bld Pos Ql NAA+probe
2019-09-09 93396-0 Fusobacterium nucleatum DNA [Presence] by NAA with probe detection in Positive blood culture Fusobacterium nucleatum DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar F. nucleatum DNA Bld Pos Ql NAA+probe
2019-09-09 93397-8 Haemophilus influenzae DNA [Presence] by NAA with probe detection in Positive blood culture Haemophilus influenzae DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar Haem influ DNA Bld Pos Ql NAA+probe
2019-09-09 93395-2 Klebsiella pneumoniae DNA [Presence] by NAA with probe detection in Positive blood culture Klebsiella pneumoniae DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar K pneumon DNA Bld Pos Ql NAA+probe
2019-09-09 93398-6 Klebsiella oxytoca DNA [Presence] by NAA with probe detection in Positive blood culture Klebsiella oxytoca DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar K oxytoca DNA Bld Pos Ql NAA+probe
2019-09-09 93399-4 Fusobacterium necrophorum DNA [Presence] by NAA with probe detection in Positive blood culture Fusobacterium necrophorum DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar F. necrophorum DNA Bld Pos Ql NAA+probe
2019-09-09 93400-0 Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA [Presence] by NAA with probe detection in Positive blood culture Enterobacter aerogenes+Enterobacter amnigenus+Enterobacter gergoviae DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar E. aerog+amn+gergo DNA Bld Pos Ql NAA+pr
2019-09-09 93401-8 Escherichia coli DNA [Presence] by NAA with probe detection in Positive blood culture Escherichia coli DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar E coli DNA Bld Pos Ql NAA+probe
2019-09-09 93402-6 Cronobacter sakazakii DNA [Presence] by NAA with probe detection in Positive blood culture Cronobacter sakazakii DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar C sakazakii DNA Bld Pos Ql NAA+probe
2019-09-09 93403-4 Citrobacter sp DNA [Presence] by NAA with probe detection in Positive blood culture Citrobacter sp DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar Citrobac sp DNA Bld Pos Ql NAA+probe
2019-09-09 93404-2 Enterobacter cloacae complex DNA [Presence] by NAA with probe detection in Positive blood culture Enterobacter cloacae complex DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar E cloac comp DNA Bld Pos Ql NAA+probe
2019-09-09 93405-9 Bacteroides fragilis DNA [Presence] by NAA with probe detection in Positive blood culture Bacteroides fragilis DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar B fragilis DNA Bld Pos Ql NAA+probe
2019-09-09 93406-7 Acinetobacter baumannii DNA [Presence] by NAA with probe detection in Positive blood culture Acinetobacter baumannii DNA PrThr Pt Bld.pos growth Ord Probe.amp.tar A baumannii DNA Bld Pos Ql NAA+probe
2019-09-09 93407-5 Gram negative blood culture panel by NAA with probe detection in Positive blood culture Gram negative blood culture panel - Pt Bld.pos growth - Probe.amp.tar GN Bld Culture Pnl Bld Pos NAA+probe
2019-09-09 93408-3 Platelet aggregation EPINEPHrine induced in Platelet rich plasma --10 umol/L Platelet aggregation.epinephrine induced^10 umol/L RelACnc Pt PRP Qn PA Epineph 10 umol/L PRP
2019-09-09 93410-9 Platelet aggregation ristocetin induced in Platelet rich plasma --5 ug/mL Platelet aggregation.ristocetin induced^5 ug/mL RelACnc Pt PRP Qn PA Rist 5 ug/mL PRP
2019-09-09 93409-1 Platelet aggregation EPINEPHrine induced in Platelet rich plasma --5 umol/L Platelet aggregation.epinephrine induced^5 umol/L RelACnc Pt PRP Qn PA Epineph 5 umol/L PRP
2019-09-04 93373-9 Columbia - suicide severity rating scale screener - recent [C-SSRS] Columbia - suicide severity rating scale screener - recent - Pt ^Patient - C-SSRS
2019-09-04 93374-7 Suicide risk level Suicide risk level Find Pt ^Patient Ord Suicide risk level
2019-09-03 93372-1 FDA product label Indexing - national clinical trial number Indexing - national clinical trial number - - ^FDA product label Nar FDA label Indexing - NCT #
2019-08-31 93371-3 von Willebrand factor (vWf) cleaving protease activity [Enzymatic activity/volume] in Platelet poor plasma by Chromogenic method von Willebrand factor cleaving protease activity CCnc Pt PPP Qn Chromo vWF Cp Act PPP Chro-cCnc
2019-08-30 93369-7 Krebs von den Lungen-6 [Units/volume] in Serum or Plasma by Immunoassay Krebs von den Lungen-6 ACnc Pt Ser/Plas Qn IA KL-6 SerPl IA-aCnc
2019-08-30 93370-5 Anaplasma phagocytophilum and Ehrlichia chaffeensis IgG and IgM panel - Serum Anaplasma phagocytophilum & Ehrlichia chaffeensis Ab.IgG & IgM panel - Pt Ser - A phagocyt + E chaff IgG + IgM Pnl Ser
2019-08-28 93356-4 Cells with cytogenetic abnormality [#] in Blood or Tissue by Molecular genetics method Cells.cytogenetic abnormality Num Pt Bld/Tiss Qn Molgen Cells w cytogenetic abnl Bld/T
2019-08-28 93357-2 Monotypic plasma cell identification and risk stratification panel - Bone marrow by Molecular genetics method Monotypic plasma cell identification & risk stratification panel - Pt Bone mar - Molgen Mono PC ID + risk Pnl Mar
2019-08-28 93358-0 Polyclonal plasma cells/Cells counted in Bone marrow by Flow cytometry (FC) Plasma cells.polyclonal/Cells counted NFr Pt Bone mar Qn Flow cytometry Polyclonal PCs/Cells NFr Mar FC
2019-08-28 93359-8 Monotypic plasma cell DNA ploidy [Type] in Bone marrow by Flow cytometry (FC) Monotypic plasma cell DNA ploidy Type Pt Bone mar Nom Flow cytometry Monotypic PC DNA ploidy Mar FC
2019-08-28 93360-6 Monotypic plasma cell DNA index in Bone marrow by Flow cytometry (FC) Monotypic plasma cell DNA index Ratio Pt Bone mar Qn Flow cytometry Monotypic PC DNA index Mar FC-Rto
2019-08-28 93362-2 Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC) Plasma cells.monotypic population Prid Pt Bone mar Nom Flow cytometry Monotypic plasma cells Mar FC
2019-08-28 93361-4 Monotypic plasma cells in S phase/100 cells in Bone marrow by Flow cytometry (FC) Plasma cells.monotypic.S phase/100 cells NFr Pt Bone mar Qn Flow cytometry Mono PC in S Phs NFr Mar FC
2019-08-28 93363-0 Plasma cell DNA content and proliferation panel - Bone marrow by Flow cytometry (FC) Plasma cell DNA content & proliferation panel - Pt Bone mar - Flow cytometry PC DNA content + prolif Pnl Mar FC
2019-08-28 93364-8 Genetic variant diagnostic significance [Interpretation] in Blood or Tissue Narrative Genetic variant diagnostic significance Imp Pt Bld/Tiss Nar Genetic variant diag sig Bld/T-Imp
2019-08-28 93365-5 Genetic variant prognostic significance [Interpretation] in Blood or Tissue Narrative Genetic variant prognostic significance Imp Pt Bld/Tiss Nar Genetic variant prog sig Bld/T-Imp
2019-08-28 93366-3 Gene studied with no variant found [Identifier] in Blood or Tissue Nominal Gene studied with no variant found Prid Pt Bld/Tiss Nom Gene studied w no variant found Bld/T
2019-08-28 93367-1 Variant of unknown significance [Identifier] in Blood or Tissue Nominal Variant of unknown significance Prid Pt Bld/Tiss Nom Variant unknown sig Bld/T
2019-08-28 93368-9 Summary of interaction between genetic variants [Interpretation] in Blood or Tissue Narrative Summary of interaction between genetic variants Imp Pt Bld/Tiss Nar Variant interaction summary Bld/T-Imp
2019-08-27 93313-5 Platelet glycoprotein disorder [Interpretation] in Blood by Flow cytometry (FC) Narrative Platelet glycoprotein disorder Imp Pt Bld Nar Flow cytometry Platelet GP disorder Bld FC-Imp
2019-08-27 93314-3 Platelet glycoprotein VI actual/normal in Blood by Flow cytometry (FC) Platelet glycoprotein VI actual/normal RelRto Pt Bld Qn Flow cytometry Plt GPVI Act/Nor Bld FC
2019-08-27 93315-0 Platelet CD49b actual/normal in Blood by Flow cytometry (FC) Platelet CD49b actual/normal RelRto Pt Bld Qn Flow cytometry Plt CD49b Act/Nor Bld FC
2019-08-27 93316-8 Platelet CD42b actual/normal in Blood by Flow cytometry (FC) Platelet CD42b actual/normal RelRto Pt Bld Qn Flow cytometry Plt CD42b Act/Nor Bld FC
2019-08-27 93317-6 Platelet CD42a actual/normal in Blood by Flow cytometry (FC) Platelet CD42a actual/normal RelRto Pt Bld Qn Flow cytometry Plt CD42a Act/Nor Bld FC
2019-08-27 93318-4 Platelet CD61 actual/normal in Blood by Flow cytometry (FC) Platelet CD61 actual/normal RelRto Pt Bld Qn Flow cytometry Plt CD61 Act/Nor Bld FC
2019-08-27 93319-2 Platelet CD41 actual/normal in Blood by Flow cytometry (FC) Platelet CD41 actual/normal RelRto Pt Bld Qn Flow cytometry Plt CD41 Act/Nor Bld FC
2019-08-27 93320-0 Platelet surface glycoprotein disorders panel - Blood by Flow cytometry (FC) Platelet glycoprotein disorder panel - Pt Bld Qn Flow cytometry Platelet glycoprotein Pnl Bld FC
2019-08-27 93321-8 PT mixing study panel - Platelet poor plasma by Coagulation assay PT mixing study panel - Pt PPP Qn Coag PT mix Pnl PPP
2019-08-27 93323-4 Tauroursodeoxycholate [Moles/volume] in Serum or Plasma Tauroursodeoxycholate SCnc Pt Ser/Plas Qn TUDCA SerPl-sCnc
2019-08-27 93324-2 Taurolithocholate [Moles/volume] in Serum or Plasma Taurolithocholate SCnc Pt Ser/Plas Qn TLCA SerPl-sCnc
2019-08-27 93325-9 Taurohyodeoxycholate [Moles/volume] in Serum or Plasma Taurohyodeoxycholate SCnc Pt Ser/Plas Qn THDCA SerPl-sCnc
2019-08-27 93326-7 Taurodeoxycholate [Moles/volume] in Serum or Plasma Taurodeoxycholate SCnc Pt Ser/Plas Qn TDCA SerPl-sCnc
2019-08-27 93327-5 Taurocholate [Moles/volume] in Serum or Plasma Taurocholate SCnc Pt Ser/Plas Qn TCA SerPl-sCnc
2019-08-27 93328-3 Taurochenodeoxycholate [Moles/volume] in Serum or Plasma Taurochenodeoxycholate SCnc Pt Ser/Plas Qn TCDCA SerPl-sCnc
2019-08-27 93329-1 Hyodeoxycholate [Moles/volume] in Serum or Plasma Hyodeoxycholate SCnc Pt Ser/Plas Qn HDCA SerPl-sCnc
2019-08-27 93330-9 Glycoursodeoxycholate [Moles/volume] in Serum or Plasma Glycoursodeoxycholate SCnc Pt Ser/Plas Qn GUDCA SerPl-sCnc
2019-08-27 93331-7 Glycolithocholate [Moles/volume] in Serum or Plasma Glycolithocholate SCnc Pt Ser/Plas Qn GLCA SerPl-sCnc
2019-08-27 93332-5 Glycohyodeoxycholate [Moles/volume] in Serum or Plasma Glycohyodeoxycholate SCnc Pt Ser/Plas Qn Glycohyodeoxycholate SerPl-sCnc
2019-08-27 93333-3 Glycodeoxycholate [Moles/volume] in Serum or Plasma Glycodeoxycholate SCnc Pt Ser/Plas Qn GDCA SerPl-sCnc
2019-08-27 93334-1 Glycocholate [Moles/volume] in Serum or Plasma Glycocholate SCnc Pt Ser/Plas Qn GCA SerPl-sCnc
2019-08-27 93335-8 Glycochenodeoxycholate [Moles/volume] in Serum or Plasma Glycochenodeoxycholate SCnc Pt Ser/Plas Qn GCDCA SerPl-sCnc
2019-08-27 93336-6 Bile acid [Moles/time] in 48 hour Stool Bile acid SRat 48H Stool Qn Bile Ac 48h Stl-sRate
2019-08-27 93337-4 Chenodeoxycholate+Cholate/Bile acid.total in 48 hour Stool Chenodeoxycholate+Cholate/Bile acid.total SFr 48H Stool Qn CDCA+CA 48h SFr Stl
2019-08-27 93338-2 Bile acid panel - 48 hour Stool Bile acid panel - 48H Stool - Bile acid pnl Stl
2019-08-27 93339-0 THSD7A IgG Ab [Presence] in Serum by Immunofluorescence Thrombospondin type I domain-containing 7A Ab.IgG PrThr Pt Ser/Plas Ord IF THSD7A IgG Ser Ql IF
2019-08-27 93340-8 PhenX - complete blood count protocol 220501 PhenX - complete blood count protocol 220501 - Pt ^Patient - PhenX PhenX - CBC protocol
2019-08-27 93341-6 Medication recommendation Medication recommendation Imp Pt ^Patient Nar Medication recommendation
2019-08-27 93342-4 Power level --peak during exercise Power level^peak during exercise EngRat Pt ^Patient Qn Power lev peak W exer
2019-08-27 93343-2 Treatment to which interaction between genetic variants confers synergy [Identifier] in Blood or Tissue Nominal Treatment to which interaction between genetic variants confers synergy Prid Pt Bld/Tiss Nom Variant interaction assoc therapy syner
2019-08-27 93344-0 Treatment to which genetic variant confers resistance [Identifier] in Blood or Tissue Nominal Treatment to which genetic variant confers resistance Prid Pt Bld/Tiss Nom Variant assoc therapy resist
2019-08-27 93345-7 Genetic variant effect on drug resistance in Blood or Tissue Narrative Genetic variant effect on drug resistance Find Pt Bld/Tiss Nar Variant drug resist effect Nar
2019-08-27 93346-5 Genetic variant effect on drug sensitivity in Blood or Tissue Narrative Genetic variant effect on drug sensitivity Find Pt Bld/Tiss Nar Variant drug sens effect Nar
2019-08-27 93347-3 Available treatment related to genetic variant and not to patient diagnosis [Identifier] in Blood or Tissue Nominal Available treatment related to genetic variant and not to patient diagnosis Prid Pt Bld/Tiss Nom Avail tx for variant but not dx Bld/T
2019-08-27 93348-1 Available treatment related to genetic variant and to patient diagnosis [Identifier] in Blood or Tissue Nominal Available treatment related to genetic variant and to patient diagnosis Prid Pt Bld/Tiss Nom Avail tx for variant+dx Bld/T
2019-08-27 93349-9 Treatment to which interaction between genetic variants confers resistance [Identifier] in Blood or Tissue Nominal Treatment to which interaction between genetic variants confers resistance Prid Pt Bld/Tiss Nom Variant interaction assoc therapy resist
2019-08-27 93350-7 Monocytes.HLA-DR/100 Monocytes in Blood by Flow cytometry (FC) Monocytes.HLA-DR/100 Monocytes NFr Pt Bld Qn Flow cytometry Mono.HLA-DR/100 Mono NFr Bld FC
2019-08-27 93351-5 HLA-DR Ag [Entitic number] on Monocyte by Flow cytometry (FC) HLA-DR Ag EntNum Pt Monocyte Qn Flow cytometry HLA-DR Ag EntNum Mono FC
2019-08-27 93352-3 Neutrophils.CD64/100 Neutrophils in Blood by Flow cytometry (FC) Neutrophils.CD64/100 Neutrophils NFr Pt Bld Qn Flow cytometry Neut.CD64/100 Neut NFr Bld FC
2019-08-27 93353-1 CD64 Ag [Entitic number] on Neutrophil by Flow cytometry (FC) CD64 Ag EntNum Pt Neutrophil Qn Flow cytometry CD64 Ag EntNum Neut FC
2019-08-27 93354-9 Neutrophil CD64 and Monocyte HLA DR panel - Blood by Flow cytometry (FC) Neutrophil CD64 & Monocyte HLA DR panel - Pt Bld Qn Flow cytometry Neut CD64 + Mono HLA DR Pnl Bld FC
2019-08-26 93305-1 Lethality [C-SSRS] Lethality - Pt ^Patient - C-SSRS
2019-08-26 93306-9 Genetic risk score for coronary heart disease Genetic risk score for coronary heart disease Score Lifetime ^Patient Qn GRS for CHD
2019-08-26 93307-7 Lifetime risk for developing coronary heart disease based on genetic risk score Lifetime risk for developing coronary heart disease based on genetic risk score Likelihood Lifetime ^Patient Ord Lifetime Risk for CHD based on GRS
2019-08-26 93308-5 Genetic variation's effect on risk of adverse drug reaction Risk of adverse drug reaction sequence variation interpretation Imp Pt Bld/Tiss Nar Adverse drug seq var interp Bld/T-Imp
2019-08-26 93309-3 Hearing.ability to hear during 3 day assessment period [CMS Assessment] Hearing.ability to hear during 3D assessment period Find 3D ^Patient Ord CMS Assessment
2019-08-26 93310-1 Vision.ability to see in adequate light during 3 day assessment period [CMS Assessment] Vision.ability to see in adequate light during 3D assessment period Find 3D ^Patient Ord CMS Assessment
2019-08-23 93232-7 Imipenem+Relebactam [Susceptibility] by Gradient strip Imipenem+Relebactam Susc Pt Isolate OrdQn Gradient strip Imi+Rel Islt Grad strip
2019-08-23 93233-5 Intercellular substance IgG Ab [Presence] in Serum by Immunofluorescence Intercellular substance Ab.IgG PrThr Pt Ser Ord IF ICS IgG Ser Ql IF
2019-08-23 93234-3 dRVVT in Platelet poor plasma by Coagulation assay --post heparin neutralization Coagulation dilute Russell viper venom induced^post heparin neutralization Time Pt PPP Qn Coag dRVVT p hep neut PPP
2019-08-23 93235-0 aPTT.lupus sensitive in Platelet poor plasma by Coagulation assay --post heparin neutralization Coagulation surface induced.lupus sensitive^post heparin neutralization Time Pt PPP Qn Coag aPTT-LA p hep neut PPP
2019-08-23 93236-8 aPTT.lupus sensitive.excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization Coagulation surface induced.lupus sensitive.excess phospholipid^post heparin neutralization Time Pt PPP Qn Coag aPTT-LA confirm p hep neut PPP
2019-08-23 93238-4 dRVVT excess phospholipid in Platelet poor plasma by Coagulation assay --post heparin neutralization Coagulation dilute Russell viper venom induced.excess phospholipid^post heparin neutralization Time Pt PPP Qn Coag dRVVT confirm p hep neut PPP
2019-08-23 93237-6 aPTT.lupus sensitive.excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization Coagulation surface induced.lupus sensitive.excess phospholipid actual/Normal^post heparin neutralization RelTime Pt PPP Qn Coag aPTT-LA confirm Act/Nor p hep neut PPP
2019-08-23 93240-0 dRVVT factor substitution in Platelet poor plasma by Coagulation assay --immediately after 1:1 addition of normal plasma and heparin neutralization Coagulation dilute Russell viper venom induced.factor substitution^immediately after 1:1 addition of normal plasma+heparin neutralization Time Pt PPP Qn Coag dRVVT imm 1:1 NP+hep neut PPP
2019-08-23 93239-2 dRVVT excess phospholipid actual/normal in Platelet poor plasma by Coagulation assay --post heparin neutralization Coagulation dilute Russell viper venom induced.excess phospholipid actual/normal^post heparin neutralization RelTime Pt PPP Qn Coag dRVVT confirm Act/Nor p hep neut PPP
2019-08-23 93241-8 US.doppler Unspecified body region Multisection Find Pt XXX Doc US.doppler DOP Unsp region
2019-08-23 93242-6 11-Ketotestosterone [Mass/volume] in Serum or Plasma 11-Ketotestosterone MCnc Pt Ser/Plas Qn 11Ketotestost SerPl-mCnc
2019-08-23 93243-4 11-Hydroxytestosterone [Mass/volume] in Serum or Plasma 11-Hydroxytestosterone MCnc Pt Ser/Plas Qn 11OH-Testost SerPl-mCnc
2019-08-23 93244-2 Complement Sc5b-9 [Mass/volume] in Serum or Plasma by Immunoassay Complement Sc5b-9 MCnc Pt Ser/Plas Qn IA SC5b9 SerPl IA-mCnc
2019-08-23 93245-9 Columbia - suicide severity rating scale - lifetime recent [C-SSRS] Columbia - suicide severity rating scale - lifetime recent - Pt ^Patient - C-SSRS
2019-08-23 93246-7 Wish to be dead 1 month Wish to be dead Find 1Mo ^Patient Ord
2019-08-23 93247-5 Non-specific active suicidal thoughts 1 month Non-specific active suicidal thoughts Find 1Mo ^Patient Ord
2019-08-23 93248-3 Active suicidal ideation with any methods (not plan) without intent to act 1 month Active suicidal ideation with any methods (not plan) without intent to act Find 1Mo ^Patient Ord
2019-08-23 93249-1 Active suicidal ideation with some intent to act, without specific plan 1 month Active suicidal ideation with some intent to act, without specific plan Find 1Mo ^Patient Ord
2019-08-23 93250-9 Active suicidal ideation with specific plan and intent 1 month Active suicidal ideation with specific plan and intent Find 1Mo ^Patient Ord
2019-08-23 93251-7 Duration of most severe suicidal ideation Lifetime [C-SSRS] Duration of most severe suicidal ideation Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93252-5 Duration of most severe suicidal ideation 1 month [C-SSRS] Duration of most severe suicidal ideation Find 1Mo ^Patient Ord C-SSRS
2019-08-23 93253-3 Actual suicide attempt Lifetime Actual suicide attempt Find Lifetime ^Patient Ord
2019-08-23 93254-1 Actual suicide attempts # Lifetime Actual suicide attempts Num Lifetime ^Patient Qn
2019-08-23 93255-8 Actual suicide attempt 3 months Actual suicide attempt Find 3Mo ^Patient Ord
2019-08-23 93256-6 Actual suicide attempts # 3 months Actual suicide attempts Num 3Mo ^Patient Qn
2019-08-23 93257-4 Has subject engaged in non-suicidal self-injurious behavior Lifetime Has subject engaged in non-suicidal self-injurious behavior Find Lifetime ^Patient Ord
2019-08-23 93258-2 Has subject engaged in non-suicidal self-injurious behavior 3 months Has subject engaged in non-suicidal self-injurious behavior Find 3Mo ^Patient Ord
2019-08-23 93259-0 Interrupted suicide attempt Lifetime Interrupted suicide attempt Find Lifetime ^Patient Ord
2019-08-23 93260-8 Interrupted suicide attempts # Lifetime Interrupted suicide attempts Num Lifetime ^Patient Qn
2019-08-23 93261-6 Interrupted suicide attempt 3 months Interrupted suicide attempt Find 3Mo ^Patient Ord
2019-08-23 93262-4 Interrupted suicide attempts # 3 months Interrupted suicide attempts Num 3Mo ^Patient Qn
2019-08-23 93263-2 Aborted or self-interrupted suicide attempt Lifetime Aborted or self-interrupted suicide attempt Find Lifetime ^Patient Ord
2019-08-23 93264-0 Aborted or self-interrupted suicide attempts # Lifetime Aborted or self-interrupted suicide attempts Num Lifetime ^Patient Qn
2019-08-23 93265-7 Aborted or self-interrupted suicide attempt 3 months Aborted or self-interrupted suicide attempt Find 3Mo ^Patient Ord
2019-08-23 93266-5 Aborted or self-interrupted suicide attempts # 3 months Aborted or self-interrupted suicide attempts Num 3Mo ^Patient Qn
2019-08-23 93268-1 Preparatory acts or suicidal behaviors # Lifetime Preparatory acts or suicidal behaviors Num Lifetime ^Patient Qn
2019-08-23 93269-9 Preparatory acts or suicidal behavior 3 months Preparatory acts or suicidal behavior Find 3Mo ^Patient Ord
2019-08-23 93267-3 Preparatory acts or suicidal behavior Lifetime Preparatory acts or suicidal behavior Find Lifetime ^Patient Ord
2019-08-23 93270-7 Preparatory acts or suicidal behaviors # 3 months Preparatory acts or suicidal behaviors Num 3Mo ^Patient Ord
2019-08-23 93271-5 Actual lethality/medical damage most lethal suicide attempt Lifetime [C-SSRS] Actual lethality or medical damage most lethal suicide attempt Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93272-3 Potential lethality most lethal suicide attempt Lifetime [C-SSRS] Potential lethality most lethal suicide attempt Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93275-6 Date of most lethal suicide attempt Date of most lethal suicide attempt Date Pt ^Patient Qn
2019-08-23 93278-0 Suicidal ideation [C-SSRS] Suicidal ideation - Pt ^Patient - C-SSRS
2019-08-23 93279-8 Most severe suicidal ideation description 1 month Most severe suicidal ideation description Find 1Mo ^Patient Nom
2019-08-23 93280-6 Most severe suicidal ideation description Lifetime Most severe suicidal ideation description Find Lifetime ^Patient Nom
2019-08-23 93281-4 Potential lethality initial/first suicide attempt [C-SSRS] Potential lethality initial or first suicide attempt Find Pt ^Patient Ord C-SSRS
2019-08-23 93282-2 Potential lethality most recent suicide attempt [C-SSRS] Potential lethality most recent suicide attempt Find Pt ^Patient Ord C-SSRS
2019-08-23 93283-0 Actual lethality/medical damage initial/first suicide attempt type [C-SSRS] Actual lethality or medical damage initial or first suicide attempt Find Pt ^Patient Ord C-SSRS
2019-08-23 93284-8 Actual lethality/medical damage most recent suicide attempt [C-SSRS] Actual lethality or medical damage most recent suicide attempt Find Pt ^Patient Ord C-SSRS
2019-08-23 93285-5 Reasons for most severe suicidal ideation 1 month [C-SSRS] Reasons for most severe suicidal ideation Find 1Mo ^Patient Ord C-SSRS
2019-08-23 93286-3 Reasons for most severe suicidal ideation Lifetime [C-SSRS] Reasons for most severe suicidal ideation Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93287-1 Deterrents of most severe suicidal ideation 1 month [C-SSRS] Deterrents of most severe suicidal ideation Find 1Mo ^Patient Ord C-SSRS
2019-08-23 93288-9 Deterrents of most severe suicidal ideation Lifetime [C-SSRS] Deterrents of most severe suicidal ideation Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93289-7 Controllability of most severe suicidal ideation 1 month [C-SSRS] Controllability of most severe suicidal ideation Find 1Mo ^Patient Ord C-SSRS
2019-08-23 93290-5 Controllability of most severe suicidal ideation Lifetime [C-SSRS] Controllability of most severe suicidal ideation Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93291-3 Frequency of most severe suicidal ideation 1 month [C-SSRS] Frequency of most severe suicidal ideation Find 1Mo ^Patient Ord C-SSRS
2019-08-23 93292-1 Frequency of most severe suicidal ideation Lifetime [C-SSRS] Frequency of most severe suicidal ideation Find Lifetime ^Patient Ord C-SSRS
2019-08-23 93295-4 Active suicidal ideation with specific plan and intent Lifetime Active suicidal ideation with specific plan and intent Find Lifetime ^Patient Ord
2019-08-23 93293-9 Most severe suicidal ideation 1 month Most severe suicidal ideation Type 1Mo ^Patient Ord
2019-08-23 93294-7 Most severe suicidal ideation Lifetime Most severe suicidal ideation Type Lifetime ^Patient Ord
2019-08-23 93298-8 Non-specific active suicidal thoughts Lifetime Non-specific active suicidal thoughts Find Lifetime ^Patient Ord Non-specific active suicidal thoughts
2019-08-23 93296-2 Active suicidal ideation with some intent to act, without specific plan Lifetime Active suicidal ideation with some intent to act, without specific plan Find Lifetime ^Patient Ord
2019-08-23 93297-0 Active suicidal ideation with any methods (not plan) without intent to act Lifetime Active suicidal ideation with any methods (not plan) without intent to act Find Lifetime ^Patient Ord
2019-08-23 93299-6 Wish to be dead Lifetime Wish to be dead Find Lifetime ^Patient Ord Wish to be dead
2019-08-23 93301-0 Date of initial/first suicide attempt Date of initial or first suicide attempt Date Pt ^Patient Qn
2019-08-23 93302-8 Date of most recent suicide attempt Date of most recent suicide attempt Date Pt ^Patient Qn
2019-08-23 93303-6 Intensity of ideation [C-SSRS] Intensity of ideation - Pt ^Patient - C-SSRS
2019-08-23 93304-4 Suicidal behavior [C-SSRS] Suicidal behavior - Pt ^Patient - C-SSRS
2019-08-22 93231-9 LCDS v5.00 - Administrative information - unplanned discharge [CMS Assessment] LCDS v5.00 - Administrative information - unplanned discharge - Pt ^Patient - CMS Assessment
2019-08-21 93224-4 Coccidioides sp Ag [Mass/volume] in Bronchoalveolar lavage by Immunoassay Coccidioides sp Ag MCnc Pt BAL Qn IA Coccidioides Ag BAL IA-mCnc
2019-08-21 93225-1 Coccidioides sp Ag [Mass/volume] in Cerebral spinal fluid by Immunoassay Coccidioides sp Ag MCnc Pt CSF Qn IA Coccidioides Ag CSF IA-mCnc
2019-08-21 93226-9 Coccidioides sp Ag [Mass/volume] in Serum or Plasma by Immunoassay Coccidioides sp Ag MCnc Pt Ser/Plas Qn IA Coccidioides Ag SerPl IA-mCnc
2019-08-21 93227-7 Coccidioides sp Ag [Mass/volume] in Urine by Immunoassay Coccidioides sp Ag MCnc Pt Urine Qn IA Coccidioides Ag Ur IA-mCnc
2019-08-21 93228-5 LCDS v5.00 - Patient demographic information - unplanned discharge and expired [CMS Assessment] LCDS v5.00 - Patient demographic information - unplanned discharge and expired - Pt ^Patient - CMS Assessment
2019-08-21 93230-1 LCDS v5.00 - Patient demographic information - planned discharge [CMS Assessment] LCDS v5.00 - Patient demographic information - planned discharge - Pt ^Patient - CMS Assessment
2019-08-21 93229-3 LCDS v5.00 - Patient demographic information - admission [CMS Assessment] LCDS v5.00 - Patient demographic information - admission - Pt ^Patient - CMS Assessment
2019-08-20 93189-9 XR Wrist and Hand Total skeletal maturity score Total skeletal maturity score Score Pt Upper extremity>Wrist+Hand Qn XR XR Wrist+Hand Total maturity score
2019-08-20 93190-7 HTR2A gene c.614-2211T>C [Genotype] in Blood or Tissue by Molecular genetics method Nominal HTR2A gene.c.614-2211T>C Geno Pt Bld/Tiss Nom Molgen HTR2A c.614-2211T>C Geno Bld/T
2019-08-20 93191-5 HTR2C gene c.-759C>T [Genotype] in Blood or Tissue by Molecular genetics method Nominal HTR2C gene.c.-759C>T Geno Pt Bld/Tiss Nom Molgen HTR2C c.-759C>T Geno Bld/T
2019-08-20 93192-3 HTR2C gene c.551-3008C>G [Genotype] in Blood or Tissue by Molecular genetics method Nominal HTR2C gene.c.551-3008C>G Geno Pt Bld/Tiss Nom Molgen HTR2C c.551-3008C>G Geno Bld/T
2019-08-20 93193-1 TPMT gene and NUDT15 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method TPMT gene & NUDT15 gene targeted mutation analysis Find Pt Bld/Tiss Doc Molgen TPMT + NUDT15 Mut Anl Bld/T
2019-08-20 93194-9 NUDT15 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal NUDT15 gene targeted mutation analysis Prid Pt Bld/Tiss Nom Molgen NUDT15 gene Mut Anl Bld/T
2019-08-20 93195-6 NUDT15 gene product metabolic activity interpretation in Blood or Tissue Qualitative NUDT15 gene product metabolic activity interpretation Imp Pt Bld/Tiss Ord NUDT15 gene prod met act imp Bld/T-Imp
2019-08-20 93196-4 Warfarin response genotype panel - Blood or Tissue by Molecular genetics method Warfarin response genotype panel - Pt Bld/Tiss - Molgen Warfarin genotype pnl Bld/T
2019-08-20 93197-2 CYP4F2 gene c.1297G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal CYP4F2 gene.c.1297G>A Geno Pt Bld/Tiss Nom Molgen CYP4F2 c.1297G>A Geno Bld/T
2019-08-20 93198-0 10q23 g.94645745G>A [Genotype] in Blood or Tissue by Molecular genetics method Nominal 10q23 g.94645745G>A Geno Pt Bld/Tiss Nom Molgen 10q23 g.94645745G>A Geno Bld/T
2019-08-20 93199-8 DPYD gene targeted mutation analysis in Blood or Tissue by Molecular genetics method DPYD gene targeted mutation analysis Find Pt Bld/Tiss Doc Molgen DPYD gene Mut Anl Bld/T
2019-08-20 93200-4 Ehlers-Danlos syndrome multigene analysis in Blood or Tissue by Molecular genetics method Ehlers-Danlos syndrome multigene analysis Find Pt Bld/Tiss Doc Molgen EDS Multigene Anl Bld/T
2019-08-20 93201-2 Coronary heart disease multigene analysis in Blood or Tissue by Molecular genetics method Coronary heart disease multigene analysis Find Pt Bld/Tiss Doc Molgen CHD Multigene Anl Bld/T
2019-08-20 93202-0 Ventilator weaning status [CMS Assessment] Ventilator weaning status Find Pt ^Patient Ord CMS Assessment
2019-08-20 93203-8 LCDS v5.00 - Spontaneous breathing trial [CMS Assessment] LCDS v5.00 - Spontaneous breathing trial - Pt ^Patient - CMS Assessment
2019-08-20 93204-6 LCDS v5.00 - Special treatments, procedures, and programs - discharge [CMS Assessment] LCDS v5.00 - Special treatments, procedures, and programs - discharge - Pt ^Patient - CMS Assessment
2019-08-20 93205-3 LCDS v5.00 - Special treatments, procedures, and programs - admission [CMS Assessment] LCDS v5.00 - Special treatments, procedures, and programs - admission - Pt ^Patient - CMS Assessment
2019-08-20 93207-9 LCDS v5.00 - Swallowing/nutritional status - admission [CMS Assessment] LCDS v5.00 - Swallowing &or nutritional status - admission - Pt ^Patient - CMS Assessment
2019-08-20 93209-5 LCDS v5.00 - Functional abilities and goals - planned discharge [CMS Assessment] LCDS v5.00 - Functional abilities and goals - planned discharge - 3D ^Patient - CMS Assessment
2019-08-20 93208-7 LCDS v5.00 - Health conditions - admission [CMS Assessment] LCDS v5.00 - Health conditions - admission - Pt ^Patient - CMS Assessment
2019-08-20 93210-3 LCDS v5.00 - Functional abilities and goals - admission [CMS Assessment] LCDS v5.00 - Functional abilities and goals - admission - Pt ^Patient - CMS Assessment
2019-08-20 93211-1 LCDS v5.00 - Cognitive patterns - unplanned discharge [CMS Assessment] LCDS v5.00 - Cognitive patterns - unplanned discharge - Pt ^Patient - CMS Assessment
2019-08-20 93212-9 LCDS v5.00 - Cognitive patterns - planned discharge [CMS Assessment] LCDS v5.00 - Cognitive patterns - planned discharge - Pt ^Patient - CMS Assessment
2019-08-20 93213-7 LCDS v5.00 - Cognitive patterns [CMS Assessment] LCDS v5.00 - Cognitive patterns - Pt ^Patient - CMS Assessment
2019-08-20 93214-5 LCDS v5.00 - Hearing, speech, and vision - discharge [CMS Assessment] LCDS v5.00 - Hearing, speech, and vision - discharge - Pt ^Patient - CMS Assessment
2019-08-20 93215-2 LCDS v5.00 - Hearing, speech, and vision - admission [CMS Assessment] LCDS v5.00 - Hearing, speech, and vision - admission - Pt ^Patient - CMS Assessment
2019-08-20 93216-0 LCDS v5.00 - Administrative information - expired [CMS Assessment] LCDS v5.00 - Administrative information - expired - Pt ^Patient - CMS Assessment
2019-08-20 93217-8 LCDS v5.00 - Administrative information - planned discharge [CMS Assessment] LCDS v5.00 - Administrative information - planned discharge - Pt ^Patient - CMS Assessment
2019-08-20 93218-6 LCDS v5.00 - Administrative information - admission [CMS Assessment] LCDS v5.00 - Administrative information - admission - Pt ^Patient - CMS Assessment
2019-08-20 93219-4 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00 [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Expired - version 5.00 - Pt ^Patient - CMS Assessment
2019-08-20 93220-2 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00 [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Unplanned Discharge - version 5.00 - Pt ^Patient - CMS Assessment
2019-08-20 93222-8 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00 [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Admission - version 5.00 - Pt ^Patient - CMS Assessment
2019-08-20 93221-0 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00 [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - Planned Discharge - version 5.00 - Pt ^Patient - CMS Assessment
2019-08-20 93223-6 Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00 [CMS Assessment] Long-Term Care Hospital (LTCH) Continuity Assessment Record and Evaluation (CARE) Data Set (LCDS) - version 5.00 - Pt ^Patient - CMS Assessment
2019-08-13 93188-1 IRF-PAI v4.0 - Administrative information - discharge [CMS Assessment] IRF-PAI v4.0 - Administrative information - discharge - Pt ^Patient - CMS Assessment
2019-08-12 93187-3 Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel Bone age assessment - Tanner-Whitehouse (TW2) associated observations panel - Pt ^Patient - Bone age assess TW2 panel
2019-08-09 93153-5 Drug classes of medications taken Drug classes of medications taken Type Pt ^Patient Nom
2019-08-09 93155-0 High risk drug classes - use and indication [CMS Assessment] High risk drug classes - use and indication - Pt ^Patient - CMS Assessment
2019-08-09 93154-3 Drug classes that have an indication documented [CMS Assessment] Drug classes that have an indication documented Type Pt ^Patient Nom CMS Assessment
2019-08-09 93156-8 How much of the time has pain made it hard for you to sleep at night over the past 5 days [CMS Assessment] How much of the time has pain made it hard for you to sleep at night over the past 5D Find 5D ^Patient Ord CMS Assessment
2019-08-09 93157-6 How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy [SILS] How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor or pharmacy Find Pt ^Patient Ord SILS
2019-08-09 93158-4 How often have you limited your day-to-day activities because of pain over the past 5 days [CMS Assessment] How often have you limited your day-to-day activities because of pain over the past 5D Find 5D ^Patient Ord CMS Assessment
2019-08-09 93159-2 How often do you feel lonely or isolated from those around you [CMS Assessment] How often do you feel lonely or isolated from those around you Find Pt ^Patient Ord CMS Assessment
2019-08-09 93161-8 IRF-PAI v4.0 - Administrative information [CMS Assessment] IRF-PAI v4.0 - Administrative information - Pt ^Patient - CMS Assessment
2019-08-09 93160-0 How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5 days [CMS Assessment] How often have you limited your participation in rehabilitation therapy sessions due to pain over the past 5D Find 5D ^Patient Ord CMS Assessment
2019-08-09 93162-6 IRF-PAI v4.0 - Cognitive patterns - admission [CMS Assessment] IRF-PAI v4.0 - Cognitive patterns - admission - Pt ^Patient - CMS Assessment
2019-08-09 93163-4 IRF-PAI v4.0 - Cognitive patterns - discharge [CMS Assessment] IRF-PAI v4.0 - Cognitive patterns - discharge - Pt ^Patient - CMS Assessment
2019-08-09 93164-2 IRF-PAI v4.0 - Health conditions - admission [CMS Assessment] IRF-PAI v4.0 - Health conditions - admission - Pt ^Patient - CMS Assessment
2019-08-09 93167-5 IRF-PAI v4.0 - Identification information [CMS Assessment] IRF-PAI v4.0 - Identification information - Pt ^Patient - CMS Assessment
2019-08-09 93165-9 IRF-PAI v4.0 - Hearing, speech, and vision - admission [CMS Assessment] IRF-PAI v4.0 - Hearing, speech, and vision - admission - Pt ^Patient - CMS Assessment
2019-08-09 93166-7 IRF-PAI v4.0 - Hearing, speech, and vision - discharge [CMS Assessment] IRF-PAI v4.0 - Hearing, speech, and vision - discharge - Pt ^Patient - CMS Assessment
2019-08-09 93170-9 IRF-PAI v4.0, LCDS v5.00 - Mood [CMS Assessment] IRF-PAI v4.0, LCDS v5.00 - Mood - Pt ^Patient - CMS Assessment
2019-08-09 93168-3 IRF-PAI v4.0, LCDS v5.00 - Medications - admission [CMS Assessment] IRF-PAI v4.0, LCDS v5.00 - Medications - admission - Pt ^Patient - CMS Assessment
2019-08-09 93169-1 IRF-PAI v4.0, LCDS v5.00 - Medications - discharge and expired [CMS Assessment] IRF-PAI v4.0, LCDS v5.00 - Medications - discharge - Pt ^Patient - CMS Assessment
2019-08-09 93171-7 IRF-PAI v4.0 - Quality indicators - admission [CMS Assessment] IRF-PAI v4.0 - Quality indicators - admission - Pt ^Patient - CMS Assessment
2019-08-09 93172-5 IRF-PAI v4.0 - Quality indicators - discharge [CMS Assessment] IRF-PAI v4.0 - Quality indicators - discharge - Pt ^Patient - CMS Assessment
2019-08-09 93173-3 IRF-PAI v4.0 - Special treatments, procedures, and programs - admission [CMS Assessment] IRF-PAI v4.0 - Special treatments, procedures, and programs - admission - Pt ^Patient - CMS Assessment
2019-08-09 93176-6 IRF-PAI v4.0, LCDS v5.00 - Swallowing/nutritional status - discharge [CMS Assessment] IRF-PAI v4.0, LCDS v5.00 - Swallowing &or nutritional status - discharge - Pt ^Patient - CMS Assessment
2019-08-09 93175-8 IRF-PAI v4.0 - Swallowing/nutritional status - admission [CMS Assessment] IRF-PAI v4.0 - Swallowing &or nutritional status - admission - Pt ^Patient - CMS Assessment
2019-08-09 93174-1 IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge [CMS Assessment] IRF-PAI v4.0 - Special treatments, procedures, and programs - discharge - Pt ^Patient - CMS Assessment
2019-08-09 93177-4 IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired or transfer [CMS Assessment] IRF-PAI v4.0, LCDS v5.00 - Health conditions - discharge or expired or transfer - Pt ^Patient - CMS Assessment
2019-08-09 93178-2 Nutritional approaches [CMS Assessment] Nutritional approaches Find Pt ^Patient Nom CMS Assessment
2019-08-09 93180-8 Nutritional approaches - last 7 days and discharge [CMS Assessment] Nutritional approaches - last 7D and discharge - Pt ^Patient - CMS Assessment
2019-08-09 93181-6 Provision of current reconciled medication list to patient at discharge [CMS Assessment] Provision of current reconciled medication list to patient at discharge Find Pt ^Patient Ord CMS Assessment
2019-08-09 93182-4 Provision of current reconciled medication list to subsequent provider at discharge [CMS Assessment] Provision of current reconciled medication list to subsequent provider at discharge Find Pt ^Patient Ord CMS Assessment
2019-08-09 93183-2 Route of current reconciled medication list transmission to patient [CMS Assessment] Route of current reconciled medication list transmission to patient Find Pt ^Patient Nom CMS Assessment
2019-08-09 93184-0 Route of current reconciled medication list transmission to subsequent provider [CMS Assessment] Route of current reconciled medication list transmission to subsequent provider Find Pt ^Patient Nom CMS Assessment
2019-08-09 93185-7 Special treatments, procedures, and programs at discharge [CMS Assessment] Special treatments, procedures, and programs at discharge Find Pt ^Patient Nom CMS Assessment
2019-08-09 93186-5 Preferred language and interpreter need Preferred language & interpreter need - Pt ^Patient - Preferred lang + interp need
2019-08-08 93128-7 Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0 [CMS Assessment] Inpatient Rehabilitation Facility - Patient Assessment Instrument - version 4.0 - Pt ^Patient - CMS Assessment
2019-08-08 93129-5 XR Radius Bone development stage Bone development stage Score Pt Upper extremity>Radius Qn XR XR Radius Bone dev stage
2019-08-08 93130-3 XR Trapezoid Bone development stage Bone development stage Score Pt Upper extremity>Wrist.trapezoid Qn XR XR Trapezoid Bone dev stage
2019-08-08 93132-9 XR Scaphoid Bone development stage Bone development stage Score Pt Upper extremity>Wrist.scaphoid Qn XR XR Scaphoid Bone dev stage
2019-08-08 93131-1 XR Trapezium Bone development stage Bone development stage Score Pt Upper extremity>Wrist.trapezium Qn XR XR Trapezium Bone dev stage
2019-08-08 93133-7 XR Lunate Bone development stage Bone development stage Score Pt Upper extremity>Wrist.lunate Qn XR XR Lunate Bone dev stage
2019-08-08 93134-5 XR Triquetrum Bone development stage Bone development stage Score Pt Upper extremity>Wrist.triquetrum Qn XR XR Triquetrum Bone dev stage
2019-08-08 93135-2 XR Hamate Bone development stage Bone development stage Score Pt Upper extremity>Wrist.hamate Qn XR XR Hamate Bone dev stage
2019-08-08 93136-0 XR Capitate Bone development stage Bone development stage Score Pt Upper extremity>Wrist.capitate Qn XR XR Capitate Bone dev stage
2019-08-08 93137-8 XR Distal phalanx of thumb Bone development stage Bone development stage Score Pt Upper extremity>Thumb.distal phalanx Qn XR XR Thumb.distl phlnx Bone dev stage
2019-08-08 93138-6 XR Distal phalanx of fifth finger Bone development stage Bone development stage Score Pt Upper extremity>Finger.fifth.distal phalanx Qn XR XR Finger.5th.distl phlnx Bone dev stage
2019-08-08 93139-4 XR Distal phalanx of third finger Bone development stage Bone development stage Score Pt Upper extremity>Finger.third.distal phalanx Qn XR XR Finger.3rd.distl phlnx Bone dev stage
2019-08-08 93140-2 XR Middle phalanx of third finger Bone development stage Bone development stage Score Pt Upper extremity>Finger.third.middle phalanx Qn XR XR Finger.3rd.mid phlnx Bone dev stage
2019-08-08 93141-0 XR Middle phalanx of fifth finger Bone development stage Bone development stage Score Pt Upper extremity>Finger.fifth.middle phalanx Qn XR XR Finger.5th.mid phlnx Bone dev stage
2019-08-08 93144-4 XR Proximal phalanx of thumb Bone development stage Bone development stage Score Pt Upper extremity>Thumb.proximal phalanx Qn XR XR Thumb.prox phlnx Bone dev stage
2019-08-08 93142-8 XR Proximal phalanx of fifth finger Bone development stage Bone development stage Score Pt Upper extremity>Finger.fifth.proximal phalanx Qn XR XR Finger.5th.prox phlnx Bone dev stage
2019-08-08 93143-6 XR Proximal phalanx of third finger Bone development stage Bone development stage Score Pt Upper extremity>Finger.third.proximal phalanx Qn XR XR Finger.3rd.prox phlnx Bone dev stage
2019-08-08 93146-9 XR Third metacarpal Bone development stage Bone development stage Score Pt Upper extremity>Hand.metacarpal.third Qn XR XR Metacarpal.3rd Bone dev stage
2019-08-08 93145-1 XR Fifth metacarpal Bone development stage Bone development stage Score Pt Upper extremity>Hand.metacarpal.fifth Qn XR XR Metacarpal.5th Bone dev stage
2019-08-08 93147-7 XR First metacarpal Bone development stage Bone development stage Score Pt Upper extremity>Hand.metacarpal.first Qn XR XR Metacarpal.1st Bone dev stage
2019-08-08 93148-5 XR Ulna Bone development stage Bone development stage Score Pt Upper extremity>Ulna Qn XR XR Ulna Bone dev stage
2019-08-08 93149-3 PhenX - bone age protocol 220301 PhenX - bone age protocol 220301 - Pt ^Patient - PhenX PhenX bone age protocol
2019-08-08 93150-1 Burn management procedure note Procedure note Find Pt {Setting} Doc Burn management Burn Procedure note
2019-08-08 93151-9 Radiology Team Conference note Conference note Find Pt {Setting} Doc Radiology.team Radiology Team Conf eval note
2019-08-08 93152-7 Radiology Initial evaluation note Initial evaluation note Find Pt {Setting} Doc Radiology Radiology Initial eval note
2019-07-26 93127-9 Risk adjustment factor [Score] Risk adjustment factor Score Pt ^Patient Qn RAF Score
2019-07-25 93126-1 Comparison with previous results Comparison with previous results Find Pt ^Patient Doc Comparison with previous results
2019-07-24 93124-6 New York Heart Association Functional Classification panel New York Heart Association Functional Classification - Pt ^Patient - NYHA NYHA Functional Class
2019-07-24 93125-3 Modified 30 seconds Sit to stand --with use of upper extremities Sit to stand^with use of upper extremities NRat 30S ^Patient Qn Modified 30s Sit to Stand w extremities
2019-07-23 93122-0 Contraindicated vaccine type [Identifier] Contraindicated vaccine type ID Pt ^Patient Nom Contraindicated vaccine
2019-07-23 93123-8 Preferred vaccine type [Identifier] Preferred vaccine type ID Pt ^Patient Nom Pref vaccine
2019-07-22 93121-2 Gabapentin [Presence] in Tissue by Screen method Gabapentin PrThr Pt Tiss Ord Screen Gabapentin Tiss Ql Scn
2019-07-19 93118-8 Difficulties in pregnancy total score [NuMoM2b] Difficulties in Pregnancy total score Score Pt ^Patient Qn NuMoM2b
2019-07-19 93119-6 Dark-mediated rod adaptation time Right eye Dark-mediated rod adaptation time Time Pt Eye.right Qn Dark rod adaptation tm Eye-R
2019-07-19 93120-4 Dark-mediated rod adaptation time Left eye Dark-mediated rod adaptation time Time Pt Eye.left Qn Dark rod adaptation tm Eye-L
2019-07-10 93113-9 Meaning of work [Quality of Working Life Questionnaire for Cancer Survivors] Meaning of work - 4W ^Patient - QWLQ-CS
2019-07-10 93114-7 Perception of your work situation [Quality of Working Life Questionnaire for Cancer Survivors] Perception of your work situation - 4W ^Patient - QWLQ-CS
2019-07-10 93115-4 Atmosphere in your working environment [Quality of Working Life Questionnaire for Cancer Survivors] Atmosphere in your working environment - 4W ^Patient - QWLQ-CS
2019-07-10 93116-2 Understanding and recognition in your organization [Quality of Working Life Questionnaire for Cancer Survivors] Understanding and recognition in your organization - 4W ^Patient - QWLQ-CS
2019-07-10 93117-0 Problems due to your health situation [Quality of Working Life Questionnaire for Cancer Survivors] Problems due to your health situation - 4W ^Patient - QWLQ-CS
2019-07-09 93088-3 Quality of Working Life Questionnaire for Cancer Survivors [Quality of Working Life Questionnaire for Cancer Survivors] Quality of Working Life Questionnaire for Cancer Survivors - 4W ^Patient - QWLQ-CS
2019-07-09 93089-1 During the past 4 weeks, working gives me structure in my life [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, working gives me structure in my life Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93090-9 During the past 4 weeks, I think it is good to work [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I think it is good to work Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93091-7 During the past 4 weeks, I consider that my work gives me a goal in life [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I consider that my work gives me a goal in life Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93092-5 During the past 4 weeks, I consider my work important [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I consider my work important Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93094-1 During the past 4 weeks, I am self-confident in my work [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I am self-confident in my work Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93095-8 During the past 4 weeks, I am suited to my work [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I am suited to my work Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93093-3 During the past 4 weeks, I do my work well [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I do my work well Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93098-2 During the past 4 weeks, I feel there is a positive atmosphere in my working environment [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I feel there is a positive atmosphere in my working environment Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93096-6 During the past 4 weeks, I have control over the work I do [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I have control over the work I do Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93097-4 During the past 4 weeks, I feel powerless in my work [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I feel powerless in my work Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93101-4 During the past 4 weeks, I have good relations with my colleagues [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I have good relations with my colleagues Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93099-0 During the past 4 weeks, I have the feeling I am taken seriously by people in my working environment [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I have the feeling I am taken seriously by people in my working environment Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93100-6 During the past 4 weeks, I am content with my work [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I am content with my work Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93102-2 During the past 4 weeks, I feel valuable to my colleagues [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I feel valuable to my colleagues Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93103-0 During the past 4 weeks, my immediate superior understands my health situation and possible health problems [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, my immediate superior understands my health situation and possible health problems Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93104-8 During the past 4 weeks, I have good relations with my immediate superior [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I have good relations with my immediate superior Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93105-5 During the past 4 weeks, I consider that employees with health problems are treated well in my organization [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I consider that employees with health problems are treated well in my organization Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93106-3 During the past 4 weeks, I am content with the fringe benefits provided by my employer [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I am content with the fringe benefits provided by my employer Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93107-1 During the past 4 weeks, I am content with my current income [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I am content with my current income Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93108-9 During the past 4 weeks, because of my health situation I have problems in my work with fatigue/lack of energy [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, because of my health situation I have problems in my work with fatigue AndOr lack of energy Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93109-7 During the past 4 weeks, I am limited in my work [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, I am limited in my work Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93110-5 During the past 4 weeks, because of my health situation I have little trust in my own body [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, because of my health situation I have little trust in my own body Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93111-3 During the past 4 weeks, because of my health situation I feel uncertain about the future [Quality of Working Life Questionnaire for Cancer Survivors] During the past 4W, because of my health situation I feel uncertain about the future Find 4W ^Patient Ord QWLQ-CS
2019-07-09 93112-1 Total score [Quality of Working Life Questionnaire for Cancer Survivors] Total score Score Pt ^Patient Qn QWLQ-CS
2019-07-05 93086-7 Obstetrics Emergency procedure note Emergency procedure note Find Pt {Setting} Doc Obstetrics OB Emerg procedure note
2019-07-05 93087-5 Total score [NuPDQ] Total score Score Pt ^Patient Qn NuPDQ
2019-07-03 93085-9 Dirofilaria immitis IgG Ab [Presence] in Serum by Immunoassay Dirofilaria immitis Ab.IgG PrThr Pt Ser Ord IA D immitis IgG Ser Ql IA
2019-06-27 93061-0 Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for your medical care during pregnancy Find Pt ^Patient Ord NuPDQ
2019-06-27 93062-8 Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your weight and body shape during pregnancy Find Pt ^Patient Ord NuPDQ
2019-06-27 93063-6 Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about whether you might have an unhealthy baby Find Pt ^Patient Ord NuPDQ
2019-06-27 93064-4 Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting [NuMoM2b] Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting Find Pt ^Patient Ord NuMoM2b
2019-06-27 93065-1 Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet [NuMoM2b] Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as swollen feet Find Pt ^Patient Ord NuMoM2b
2019-06-27 93066-9 Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches [NuMoM2b] Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as backaches Find Pt ^Patient Ord NuMoM2b
2019-06-27 93059-4 Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about the effect of ongoing health problems such as high blood pressure or diabetes on your pregnancy Find Pt ^Patient Ord NuPDQ
2019-06-27 93060-2 Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about feeling tired and having low energy during your pregnancy Find Pt ^Patient Ord NuPDQ
2019-06-27 93067-7 Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about the quality of your medical care during pregnancy Find Pt ^Patient Ord NuPDQ
2019-06-27 93068-5 Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about working or caring for your family during your pregnancy Find Pt ^Patient Ord NuPDQ
2019-06-27 93069-3 Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might be affected by alcohol, cigarettes, or drugs that you have taken Find Pt ^Patient Ord NuPDQ
2019-06-27 93070-1 Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby [NuPDQ] Are there other things that you are bothered, upset or worried about that have to do with your pregnancy, the birth, or the baby Find Pt ^Patient Ord NuPDQ
2019-06-27 93071-9 Other things you are feeling bothered, upset or worried about [NuPDQ] Other things you are feeling bothered, upset or worried about Find Pt ^Patient Nom NuPDQ
2019-06-27 93072-7 Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about paying for the baby's clothes, food, or medical care Find Pt ^Patient Ord NuPDQ
2019-06-27 93073-5 Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about taking care of a newborn baby Find Pt ^Patient Ord NuPDQ
2019-06-27 93074-3 Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about pain during labor and delivery Find Pt ^Patient Ord NuPDQ
2019-06-27 93075-0 Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about whether the baby might come too early Find Pt ^Patient Ord NuPDQ
2019-06-27 93076-8 Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about physical symptoms of pregnancy such as vomiting, swollen feet, or backaches Find Pt ^Patient Ord NuPDQ
2019-06-27 93077-6 Physical symptom of pregnancy that you are feeling bothered, upset or worried about [NuPDQ] Physical symptom of pregnancy that you are feeling bothered, upset or worried about Find Pt ^Patient Nom NuPDQ
2019-06-27 93078-4 Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about changes in your relationships with other people due to having a baby Find Pt ^Patient Ord NuPDQ
2019-06-27 93079-2 Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby [NuPDQ] Person who you are feeling bothered, upset or worried about having a relationship change with due to having a baby Find Pt ^Patient Nom NuPDQ
2019-06-27 93080-0 Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about what will happen during labor and delivery Find Pt ^Patient Ord NuPDQ
2019-06-27 93081-8 Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about working at a job after the baby comes Find Pt ^Patient Ord NuPDQ
2019-06-27 93084-2 NuMoM2b Difficulties in Pregnancy form [NuMoM2b] Nulliparous Pregnancy Outcomes Study Monitoring Mothers-to-Be Difficulties in Pregnancy form - Pt ^Patient - NuMoM2b
2019-06-27 93083-4 Revised Prenatal Distress Questionnaire (NuPDQ) - Concurrent Self-Administered Version Revised Prenatal Distress Questionnaire - Concurrent Self-Administered Version - Pt ^Patient - NuPDQ
2019-06-27 93082-6 Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes [NuPDQ] Are you feeling bothered, upset, or worried at this point in your pregnancy about getting day care, babysitters, or help to watch the baby after it comes Find Pt ^Patient Ord NuPDQ
2019-06-25 93055-2 Outcome and assessment information set (OASIS) form - version D1 [CMS Assessment] Outcome and assessment information set (OASIS) form - version D1 - Pt ^Patient - CMS Assessment
2019-06-25 93056-0 OASIS D1 - Patient history and diagnoses - follow-up [CMS Assessment] OASIS D1 - Patient history and diagnoses - follow-up - Pt ^Patient - CMS Assessment
2019-06-25 93057-8 OASIS D1 - ADL and IADLs - follow-up [CMS Assessment] OASIS D1 - ADL and IADLs - follow-up - Pt ^Patient - CMS Assessment
2019-06-25 93058-6 Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up [CMS Assessment] Outcome and assessment information set (OASIS) form - version D1 - Follow-up - recertification or other follow-up - Pt ^Patient - CMS Assessment
2018-10-19 90568-7 Polysomnography panel Polysomnography panel - Stdy ^Patient - Polysomnography Pnl